Other respiratory diseases principally affecting the interstitium

J10_INTERSTITIUM

pulmonary edema: Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J80-J84 Cause of death: ICD-10 — J80-J84 2 out of 7 registries used, show all original rules.	6914
4. Check minimum number of events None	6914
5. Include endpoints J10_ARDS J10_PULMOEDEMA J10_PULMEOS J10_OTHERINSTPULM	7262
6. Filter based on genotype QC (FinnGen only)	7262

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	J10_INTERSTITIUM
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	J10_ARDS\|J10_PULMOEDEMA\|J10_PULMEOS\|J10_OTHERINSTPULM
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J8[0-4]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J8[0-4]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other respiratory diseases principally affecting the interstitium based on the number of shared cases.

Similar with more cases:

Diseases of the respiratory system

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7262	2901	4361
Unadjusted period prevalence (%)	1.55	0.99	1.92
Median age at first event (years)	68.85	66.02	70.72

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6496: Matched controls
64957

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

284

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

323.0

467

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

5458.1

323.0

2519

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

21.3

323.0

1893

1227

J80

ICD-10 Finland

Adult respiratory distress syndrome

+∞

323.0

386

TGC00

NOMESCO Finland

Bronchial lavation

28.3

323.0

1260

547

H02AB06

ATC

prednisolone; systemic

4.4

323.0

4526

22426

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

17.7

323.0

1047

698

XG410

NOMESCO Finland

Flow-volume spirometry

7.8

323.0

856

1239

UGC12

NOMESCO Finland

Flexible bronchoscopy

9.2

323.0

2036

3055

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

+∞

323.0

1440

J81

ICD-10 Finland

Pulmonary oedema

950.7

323.0

605

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.2

323.0

4048

22084

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

6.8

323.0

2066

4156

356

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

323.0

389

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

3538.0

323.0

346

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.2

323.0

3260

12653

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

9040.9

323.0

2754

R06.0

ICD-10 Finland

Dyspnoea

3.0

321.4

2490

11081

L04AX05

ATC

pirfenidone; oral

+∞

320.4

305

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

5.8

301.5

932

1815

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.1

286.0

1288

3715

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

8.8

272.5

616

761

L04AX01

ATC

azathioprine; systemic

7.4

260.2

663

987

R03AC02

ATC

salbutamol; inhalant

2.4

249.8

3673

22655

GD1AD

NOMESCO Finland

Thorax CT examination

6.2

248.5

726

1301

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.4

231.5

2750

14975

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

5.1

223.6

769

1665

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.5

220.6

1180

3857

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.0

214.3

946

2623

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.7

209.5

788

1871

L01XE31

ATC

[U] nintedanib; oral

+∞

205.2

196

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

23.9

201.8

293

128

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

66.7

199.9

232

J96.1

ICD-10 Finland

Chronic respiratory failure

7.5

196.1

491

704

L04AA06

ATC

mycophenolic acid; systemic

12.8

195.5

360

297

C03CA01

ATC

furosemide; systemic

2.2

189.0

2902

17371

J01MA14

ATC

moxifloxacin; systemic

3.5

188.1

995

3190

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

187.3

1578

6939

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

34.8

169.2

222

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

+∞

168.4

161

R03BB04

ATC

tiotropium bromide; inhalant

2.8

154.4

1143

4582

A02BC02

ATC

pantoprazole; systemic

2.0

153.8

4408

33018

48499

ICD-8 Finland

Acute interstitial pneumonia

+∞

150.6

144

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.8

137.5

487

1069

P01BA02

ATC

hydroxychloroquine; oral

3.3

137.4

754

2449

I50.9

ICD-10 Finland

Heart failure, unspecified

2.3

137.2

1534

7658

L01EX09

ATC

nintedanib; oral

+∞

135.9

130

M05BA04

ATC

alendronic acid; oral

2.9

122.9

844

3188

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.7

122.4

582

1680

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

3.6

119.2

578

1695

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

+∞

118.0

113

J01MA12

ATC

levofloxacin; systemic

2.1

116.8

1570

8432

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

114.8

1344

6774

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

113.9

1371

6998

R05

ICD-10 Finland

Cough

2.2

111.5

1402

7289

Z94.2

ICD-10 Finland

Lung transplant status

89.6

110.4

123

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

5.2

109.4

360

726

GDG10

NOMESCO Finland

Bilateral transplantation of lung

189.8

107.7

112

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.3

100.5

1077

5169

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

99.8

1699

9933

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

99.7

838

3543

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

99.0

1503

8403

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

98.9

1570

8932

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

9.9

98.4

204

212

I50.0

ICD-10 Finland

Congestive heart failure

2.5

96.2

837

3603

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.5

95.8

360

834

J45.1

ICD-10 Finland

Nonallergic asthma

2.9

92.3

604

2191

R4110

NOMESCO Finland

Physiotherapy

1.8

88.8

1817

11267

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

88.1

1419

8065

WX892

NOMESCO Finland

Monitored bed care

2.6

87.6

690

2801

J47

ICD-10 Finland

Bronchiectasis

5.4

87.1

273

519

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

85.9

1087

5589

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

295.7

85.9

R50.9

ICD-10 Finland

Fever, unspecified

2.1

81.4

1045

5395

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

81.0

2880

21004

J01AA02

ATC

doxycycline; systemic

1.7

81.0

4834

40723

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.6

80.9

665

2758

R03BA08

ATC

ciclesonide; inhalant

2.8

80.3

572

2183

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.9

79.7

540

1996

J43.9

ICD-10 Finland

Emphysema, unspecified

5.7

78.5

237

431

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

78.4

2000

13206

J01FA06

ATC

roxithromycin; oral

1.7

77.4

2492

17598

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.9

76.9

519

1911

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

75.9

1772

11355

127

Kela drug reimbursment

Transplant complication

7.3

75.8

189

266

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

75.3

1185

6623

A07EC01

ATC

sulfasalazine; oral, rectal

2.6

74.7

603

2471

ZX120

NOMESCO Finland

Intravenous

2.3

74.6

736

3357

R03AK08

ATC

formoterol and beclometasone; inhalant

3.9

74.0

324

864

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

8.2

73.8

170

212

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

7.5

72.8

177

240

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

72.8

1388

8301

L04AD01

ATC

ciclosporin; systemic

6.4

72.7

200

323

R02

ICPC

Shortness of breath/dyspnoea

2.1

72.0

902

4590

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.6

70.1

541

2160

Z3226

NOMESCO Finland

Physiotherapist

1.9

69.5

1270

7468

H02AB07

ATC

prednisone; oral

2.0

68.5

1054

5819

R04.2

ICD-10 Finland

Haemoptysis

3.2

66.0

371

1206

XG466

NOMESCO Finland

Sleep oxymetry

3.5

65.5

321

940

WW200

NOMESCO Finland

Immunization

4.2

64.7

259

637

C07AB07

ATC

bisoprolol; oral

1.6

64.5

3375

26575

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

3.4

64.3

336

1035

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

63.9

492

1956

L04AA13

ATC

leflunomide; oral

4.4

63.9

241

559

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

63.3

1931

13241

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

61.2

931

5095

ZXE00

NOMESCO Finland

One hour or less

1.6

61.1

2411

17638

Z3231

NOMESCO Finland

Registered nurse

1.6

58.9

1794

12246

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

17.8

58.9

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.4

58.3

545

2406

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

57.5

1096

6492

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

57.1

872

4771

WX872

NOMESCO Finland

Intensive care

2.6

56.4

450

1823

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.8

56.4

381

1400

J01CA04

ATC

amoxicillin; systemic

1.6

56.0

4579

39342

Z2221

NOMESCO Finland

Medical doctor

1.6

56.0

1699

11551

WX722

NOMESCO Finland

PEEP

2.7

55.5

417

1631

R03BA02

ATC

budesonide; inhalant

1.8

55.2

1060

6284

R03BA01

ATC

beclometasone; inhalant

1.9

54.4

911

5147

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

54.0

1236

7742

A02BC01

ATC

omeprazole; systemic

1.6

54.0

1834

12822

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.5

53.7

199

454

XX4BW

NOMESCO Finland

28.4

53.5

R81

ICPC

Pneumonia

3.2

53.5

293

934

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

53.2

785

4231

J96.0

ICD-10 Finland

Acute respiratory failure

5.1

52.9

174

350

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

6.9

51.6

132

194

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.8

51.4

178

379

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.4

50.5

466

2039

ZX108

NOMESCO Finland

Inhalation

7.9

49.9

117

151

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.8

49.6

217

578

D86.0

ICD-10 Finland

Sarcoidosis of lung

6.5

48.5

130

204

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

8.9

48.3

105

120

N02AX02

ATC

tramadol; systemic, rectal

1.5

48.2

2642

20493

R03DC03

ATC

montelukast; oral

1.9

47.9

845

4843

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

47.9

1865

13400

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

4.4

47.4

179

417

A07AA02

ATC

nystatin; oral

2.3

47.3

464

2090

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.2

47.1

258

823

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

47.0

1225

7930

R05

ICPC

Cough

1.7

46.8

1242

8079

R03BA05

ATC

fluticasone; inhalant

1.7

45.6

1033

6412

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

3.2

45.3

251

807

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.1

44.9

530

2601

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.3

44.3

436

1968

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

6.2

44.1

122

200

GX1K5

NOMESCO Finland

Diffusion capacity

21.2

43.9

R99

ICPC

Respiratory disease other

4.3

43.5

166

391

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

43.4

337

1343

J84

ICD-10 Finland

Other interstitial pulmonary diseases

430.4

43.2

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

8.0

42.9

125

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.7

42.4

195

543

B01AA03

ATC

warfarin; systemic

1.5

42.3

1673

11989

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.3

42.1

161

380

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.4

41.8

209

622

J01FF01

ATC

clindamycin; systemic

1.5

41.3

1556

11017

H02AB04

ATC

methylprednisolone; systemic

1.7

41.2

910

5592

ZXD05

NOMESCO Finland

Urgent procedure

1.5

40.9

1865

13777

A02BC05

ATC

esomeprazole; systemic

1.5

40.7

2298

17742

R28

ICPC

Limited function/disability (R)

4.4

40.4

150

344

Z2446

NOMESCO Finland

Social worker

2.3

40.2

406

1851

I50.1

ICD-10 Finland

Left ventricular failure

2.2

40.1

445

2123

5183A

ICD-9 Finland

Other diseases of lung, Pulmonary eosinophilia

+∞

39.6

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.7

39.4

176

479

C01DA14

ATC

isosorbide mononitrate; oral

1.6

39.1

1352

9359

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

38.9

469

2317

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

38.9

611

3349

TK800

NOMESCO Finland

Hemodialysis

3.4

38.8

195

584

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

5.3

38.1

120

231

AN1

Coronary angiography

1.7

38.0

952

6054

WX721

NOMESCO Finland

Oxygen concentrator therapy

18.0

37.9

L04AA01

ATC

[U] ciclosporin; systemic

4.5

37.5

137

310

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

37.4

475

2397

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

37.4

903

5684

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

36.5

2158

16716

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

36.2

2506

19982

J92.9

ICD-10 Finland

Pleural plaque without asbestos

4.4

36.1

136

317

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

36.0

738

4421

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.4

35.7

179

535

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.5

35.7

292

1196

J01FA10

ATC

azithromycin; systemic

1.4

35.7

2766

22494

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.2

35.5

194

619

J67.9

ICD-10 Finland

Hypersensitivity pneumonitis due to unspecified organic dust

24.0

35.2

GDA10

NOMESCO Finland

Biopsy of lung

14.9

35.2

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

35.0

651

3777

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.8

35.0

230

831

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

35.0

1545

11261

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

34.9

898

5745

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

24.7

34.8

M04AA01

ATC

allopurinol; systemic

1.6

34.7

1017

6736

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.7

34.5

158

440

JN4BD

NOMESCO Finland

Extensive body CT

1.7

34.2

757

4636

XW000

NOMESCO Finland

Bone marrow biopsy

2.4

34.2

312

1353

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

34.0

1513

11032

WZC30

NOMESCO Finland

Teaching

1.7

34.0

796

4955

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

45.8

33.7

L88

ICPC

Rheumatoid/seropositive arthritis

2.6

33.5

249

969

GX1D5

NOMESCO Finland

Flow volume spirometry

31.6

33.4

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

16.7

33.2

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

32.8

1733

13072

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

32.6

649

3846

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

32.5

1665

12477

M05BA07

ATC

risedronic acid; oral

2.5

32.0

256

1038

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

31.7

2257

17960

C03DA01

ATC

spironolactone; oral

1.7

31.6

776

4890

G47.3

ICD-10 Finland

Sleep apnoea

1.5

31.6

1140

7922

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

31.4

623

3684

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

31.2

376

1855

J45.8

ICD-10 Finland

Mixed asthma

2.7

31.1

218

817

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.5

31.0

170

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

30.9

519

2907

J46

ICD-10 Finland

Status asthmaticus

2.9

30.9

192

670

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

30.8

356

1727

A01AB09

ATC

miconazole; local oral

1.8

30.6

551

3161

J94.1

ICD-10 Finland

Fibrothorax

46.5

30.6

M34.1

ICD-10 Finland

CR(E)ST syndrome

11.8

30.3

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

7.5

30.2

WX730

NOMESCO Finland

Conventional respirator

3.4

30.2

151

452

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

29.8

425

2242

R06.2

ICD-10 Finland

Wheezing

2.4

29.8

267

1150

F1246

NOMESCO Finland

14.4

29.6

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

34.7

29.6

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

29.5

1068

7411

A03

ICPC

Fever

1.7

29.5

673

4150

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.8

29.3

515

2928

E0000UV

ATC

1.4

29.3

2084

16523

51920

ICD-8 Finland

Other diseases of respiratory system, Infiltratio pulmonis eosinophilica

+∞

29.2

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

6.2

29.1

128

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.9

29.0

467

2575

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

5.0

28.9

189

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

28.7

289

1317

M81.4

ICD-10 Finland

Drug-induced osteoporosis

9.7

28.5

N03AX16

ATC

pregabalin; oral

1.5

28.5

1297

9453

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

28.5

291

1336

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

8.0

28.5

R03DA04

ATC

theophylline; systemic, rectal

1.9

28.4

440

2392

D72.1

ICD-10 Finland

Eosinophilia

8.8

28.3

J01FA15

ATC

telithromycin; oral

1.8

28.1

510

2930

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

11.6

28.0

R03AC12

ATC

salmeterol; inhalant

2.1

27.8

332

1633

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

19.2

27.8

A02BC03

ATC

lansoprazole; oral

1.4

27.6

1731

13391

R03AK11

ATC

formoterol and fluticasone; inhalant

3.1

27.5

158

523

WX882

NOMESCO Finland

High dependency care

2.6

27.5

209

825

J43.8

ICD-10 Finland

Other emphysema

9.3

27.3

R06AE07

ATC

cetirizine; oral

1.4

27.2

2083

16671

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

6.9

27.1

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.8

27.1

179

650

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

27.1

479

2727

R03AC03

ATC

terbutaline; inhalant

1.6

27.1

735

4748

C09AA05

ATC

ramipril; oral

1.4

27.0

1696

13115

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

26.9

718

4617

J01DB01

ATC

cefalexin; oral

1.4

26.9

4632

41970

XX9XE

NOMESCO Finland

Other ultrasound examination

5.5

26.9

150

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

26.7

896

6098

JN4AD

NOMESCO Finland

Body CT examination

1.8

26.6

496

2872

I25.2

ICD-10 Finland

Old myocardial infarction

1.7

26.4

585

3569

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

3.5

26.4

125

359

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.1

26.4

312

1528

J01DA01

ATC

[U] cefalexin; systemic

1.3

26.3

3533

30760

J15.8

ICD-10 Finland

Other bacterial pneumonia

4.9

26.3

179

UJF32

NOMESCO Finland

Coloscopy

1.4

26.2

1539

11747

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.4

26.2

232

994

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

26.1

305

1483

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

11.8

26.1

L04AB01

ATC

etanercept; parenteral

4.5

25.9

209

F2680

NOMESCO Finland

11.8

25.6

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

25.5

1754

13754

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

25.3

853

5809

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.1

25.0

141

462

5169X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy

+∞

25.0

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

24.9

394

2157

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

24.9

296

1453

2AX04

NOMESCO Finland

26.3

24.8

N05CF01

ATC

zopiclone; oral

1.4

24.8

1947

15586

R03BB01

ATC

ipratropium bromide; inhalant

2.0

24.7

332

1709

WX726

NOMESCO Finland

High-flow oxygen therapy

14.7

24.6

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

24.5

578

3587

J20

ICD-10 Finland

Acute bronchitis

1.7

24.4

508

3042

R03AC13

ATC

formoterol; inhalant

2.0

24.4

321

1643

XG405

NOMESCO Finland

Education on PEF monitoring

3.6

24.3

113

321

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.1

24.2

298

1483

D07AC01

ATC

betamethasone; topical

1.4

24.2

1894

15142

WX002

NOMESCO Finland

Sedation and analgesia

1.4

23.9

1141

8359

M01CB01

ATC

sodium aurothiomalate; parenteral

3.3

23.7

120

364

J01FA09

ATC

clarithromycin; systemic

1.4

23.6

1487

11456

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

125.4

23.6

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.6

23.5

170

653

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

23.5

532

3264

XG460

NOMESCO Finland

Short time oxymetry

2.8

23.5

152

546

J43.2

ICD-10 Finland

Centrilobular emphysema

8.6

23.5

5AB14

NOMESCO Finland

19.5

23.4

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

23.3

644

4168

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

23.2

476

2839

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.5

23.1

108

308

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.9

23.1

156

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

23.0

889

6230

J01MA02

ATC

ciprofloxacin; systemic

1.3

23.0

2350

19523

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

23.0

1666

13134

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

22.9

368

2027

5185A

ICD-9 Finland

Other diseases of lung, Pulmonary insufficiency following trauma and surgery

+∞

22.9

L04AB04

ATC

adalimumab; parenteral

3.7

22.9

100

270

N18.8

ICD-10 Finland

Other chronic renal failure

2.3

22.9

224

1009

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.1

22.8

253

1206

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

22.7

1992

16167

3A006

NOMESCO Finland

230.7

22.6

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.8

22.5

407

2333

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

22.5

644

4210

XJC10

NOMESCO Finland

Oesophageal pH monitoring

6.2

22.3

RS123

NOMESCO Finland

18.0

22.1

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.9

22.1

353

1941

WZA10

NOMESCO Finland

Long statement of health and health related matters

3.9

22.1

239

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

21.9

462

2776

5163A

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis

+∞

21.9

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

21.8

269

1339

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

21.8

429

2525

SPAT1262

SPAT

Handing over of treatment supplies

1.4

21.8

1127

8367

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

21.7

338

1843

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.4

21.5

184

777

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

21.4

257

1268

J12.8

ICD-10 Finland

Other viral pneumonia

4.9

21.2

145

L01AA01

ATC

cyclophosphamide; systemic

5.5

21.2

116

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.8

21.0

139

508

Z51.5

ICD-10 Finland

Palliative care

1.7

20.9

417

2461

N02AA05

ATC

oxycodone; systemic

1.4

20.9

941

6799

J99.0

ICD-10 Finland

Rheumatoid lung disease

60.2

20.9

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

5.1

20.8

131

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.9

20.8

127

441

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

8.8

20.7

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.1

20.5

229

1096

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

20.4

245

1208

Z57.2

ICD-10 Finland

Occupational exposure to dust

6.6

20.3

B01AC04

ATC

clopidogrel; oral

1.4

20.3

1091

8147

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.1

20.3

112

364

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

4.9

20.3

135

H02AB09

ATC

hydrocortisone; systemic

2.9

20.2

127

447

N02BE01

ATC

paracetamol; systemic, rectal

1.3

20.2

5033

46831

120

Kela drug reimbursment

Hypogammaglobulinaemia

16.1

20.0

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

5.4

20.0

112

J67.0

ICD-10 Finland

Farmer lung

13.7

20.0

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

19.9

325

1798

1240

FHL

Bronchoscopy

3.1

19.9

108

347

ZXA10

NOMESCO Finland

Bilateral

1.4

19.9

1098

8232

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.9

19.9

125

441

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

3.5

19.8

278

B01AB05

ATC

enoxaparin; parenteral

1.3

19.7

1729

13972

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

19.7

253

1285

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

19.6

486

3057

Angiography of the heart and coronary arteries

1.6

19.6

522

3346

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

19.5

162

675

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

19.5

1506

11938

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

19.4

217

1039

N03AX12

ATC

gabapentin; oral

1.5

19.4

793

5611

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

19.3

167

711

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

19.1

427

2606

XQ800

NOMESCO Finland

Prick test

1.9

19.1

288

1553

L04AA24

ATC

abatacept; parenteral

8.9

19.0

A46

ICD-10 Finland

Erysipelas

1.4

19.0

856

6175

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.7

19.0

133

502

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.3

18.8

175

772

J05AB11

ATC

valaciclovir; oral

1.5

18.7

629

4263

RK320

NOMESCO Finland

3.9

18.7

199

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

14.1

18.5

R4190

NOMESCO Finland

Nutritional therapy

2.3

18.5

165

713

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

18.4

228

1140

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.3

18.4

290

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

10.0

18.3

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.5

18.2

147

602

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

18.2

1535

12305

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.4

18.1

161

692

GAA31

NOMESCO Finland

Thoracoscopy

6.3

18.1

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

18.1

1792

14700

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

18.1

287

1577

M34.0

ICD-10 Finland

Progressive systemic sclerosis

14.3

18.0

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

18.0

1447

11511

R05FB02

ATC

cough suppressants and expectorants

1.3

18.0

2117

17763

SPAT1255

SPAT

Intravenous administration of medicine

1.7

17.9

389

2356

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

17.9

392

2380

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.3

17.9

160

692

J96.9

ICD-10 Finland

Respiratory failure, unspecified

4.4

17.9

150

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.8

17.9

114

408

M33.2

ICD-10 Finland

Polymyositis

10.0

17.8

WX110

NOMESCO Finland

Local anesthesy

1.3

17.8

3435

30618

RS221

NOMESCO Finland

3.3

17.8

270

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

17.8

311

1764

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

4.2

17.8

160

M10.9

ICD-10 Finland

Gout, unspecified

1.6

17.6

446

2819

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.1

17.6

211

1043

J02AC01

ATC

fluconazole; systemic

1.3

17.5

1652

13446

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

17.5

580

3918

J99.1*M33.2

ICD-10 Finland

Respiratory disorders in polymyositis

180.4

17.5

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

15.6

17.4

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

17.4

195

934

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

8.8

17.1

D07AB08

ATC

desonide; topical

1.5

17.1

528

3509

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

17.0

2244

19066

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

5.1

17.0

104

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

2.9

17.0

105

369

R01AD12

ATC

fluticasone furoate; nasal

1.4

17.0

1148

8881

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.3

16.9

156

684

A28

ICPC

Limited function/disability NOS

1.4

16.8

1015

7713

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

14.0

16.7

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4.7

16.7

119

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

16.7

230

1200

M33.1

ICD-10 Finland

Other dermatomyositis

15.0

16.6

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

8.8

16.6

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

16.6

670

4723

SPAT1263

SPAT

Sampling

1.3

16.5

2271

19378

J18

ICD-10 Finland

Pneumonia, organism unspecified

4.1

16.5

158

C10AA03

ATC

pravastatin; oral

1.6

16.4

457

2963

5BA08

NOMESCO Finland

4.6

16.4

122

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.2

16.3

273

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.3

16.2

148

647

318

Kela drug reimbursment

Teriparatide

5.1

16.1

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

16.1

303

1759

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

30.1

16.1

ZXA00

NOMESCO Finland

Right side

1.3

16.0

1577

12886

S97

ICPC

Chronic ulcer skin

1.7

15.9

353

2152

RK110

NOMESCO Finland

3.7

15.9

188

1CX01

NOMESCO Finland

10.0

15.9

XF402

NOMESCO Finland

ECG with work load test

1.5

15.8

663

4707

M05.1

ICD-10 Finland

Rheumatoid lung disease

60.1

15.7

AK3

BLTX (both lung transplants)

+∞

15.6

C01AA05

ATC

digoxin; systemic

1.5

15.6

638

4507

XPX04

NOMESCO Finland

Angioscopy

7.1

15.5

M05BX04

ATC

denosumab; parenteral

1.7

15.5

297

1736

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

3.5

15.4

203

H26.3

ICD-10 Finland

Drug-induced cataract

5.0

15.4

RS230

NOMESCO Finland

5.9

15.4

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.1

15.3

274

B02.9

ICD-10 Finland

Zoster without complication

1.7

15.3

321

1927

ZXA05

NOMESCO Finland

Left side

1.3

15.2

1487

12118

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

9.7

15.1

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

5.0

15.1

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.9

15.1

R01AD08

ATC

fluticasone; nasal

1.3

15.1

1253

9981

1XC02

NOMESCO Finland

4.0

15.1

147

M35.1

ICD-10 Finland

Other overlap syndromes

5.1

15.1

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

23.4

15.1

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

15.0

1217

9663

GX2C5

NOMESCO Finland

Short-lasting oximetry

11.8

15.0

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.1

15.0

171

830

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

14.9

1706

14187

GX2D5

NOMESCO Finland

Sleep oximetry

7.3

14.9

I27.0

ICD-10 Finland

Primary pulmonary hypertension

8.9

14.9

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.8

14.9

281

1635

RS220

NOMESCO Finland

3.1

14.8

264

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.3

14.8

134

586

R01AD09

ATC

mometasone; nasal

1.3

14.8

2000

16975

J45

ICD-10 Finland

Asthma

1.6

14.8

442

2916

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.9

14.7

228

1242

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

14.7

295

1747

J02AC03

ATC

voriconazole; systemic

9.1

14.6

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

4.7

14.6

105

P01AB01

ATC

metronidazole; oral, rectal

1.3

14.6

1868

15743

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

3.0

14.6

282

E84.9

ICD-10 Finland

Cystic fibrosis, unspecified

+∞

14.6

E000001

ATC

1.3

14.6

998

7725

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

150.3

14.5

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.6

14.5

178

I20.09

ICD-10 Finland

Unstable angina

1.6

14.4

389

2500

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

3.3

14.3

211

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

5.4

14.3

A02BA02

ATC

ranitidine; systemic

1.3

14.3

1161

9214

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.9

14.2

289

H05AA02

ATC

teriparatide; parenteral

5.0

14.2

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.4

14.1

123

526

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.7

14.1

267

1558

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.8

14.1

337

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.6

14.0

157

2792

WW500

NOMESCO Finland

Blood transfusion

1.8

14.0

229

1273

N02AA01

ATC

morphine; systemic, rectal

2.6

13.9

103

406

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.6

13.8

356

2261

Z94.3

ICD-10 Finland

Heart and lungs transplant status

53.4

13.8

L04AA17

ATC

[U] adalimumab; parenteral

7.0

13.8

C08CA02

ATC

felodipine; oral

1.4

13.8

616

4425

4040

NOMESCO Finland

20.0

13.7

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

4.7

13.7

J93.8

ICD-10 Finland

Other pneumothorax

4.5

13.7

108

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

13.7

406

2672

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

4.4

13.6

109

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

13.5

444

2992

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.9

13.5

291

J98.4

ICD-10 Finland

Other disorders of lung

8.3

13.5

M05BA06

ATC

ibandronic acid; systemic

2.4

13.5

113

476

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.7

13.4

353

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

13.4

756

5659

R29

ICPC

Respiratory symptom/complaint other

1.7

13.4

295

1796

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

13.4

112

2162

GD1UN

NOMESCO Finland

Lung circulation SPECT

3.7

13.4

159

C08CA05

ATC

nifedipine; systemic

1.5

13.4

423

2824

J01GB01

ATC

tobramycin; inhalant, parenteral

21.2

13.3

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

13.3

1647

13797

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

13.3

339

2147

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.1

13.2

156

770

WX720

NOMESCO Finland

Own respiration

1.9

13.2

198

1070

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.0

13.2

158

784

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

40.1

13.1

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

13.1

372

2422

XF404

NOMESCO Finland

Ambulatory ECG

1.5

13.1

522

3665

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

15.0

13.1

R4120

NOMESCO Finland

Occupational therapy

1.6

13.1

311

1935

A02BA03

ATC

famotidine; systemic

1.7

13.1

250

1460

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

13.0

273

1641

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

13.0

1746

14758

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.6

13.0

302

1866

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

13.0

417

2798

J94.8

ICD-10 Finland

Other specified pleural conditions

2.3

13.0

116

506

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.6

13.0

382

2509

D07AC13

ATC

mometasone; topical

1.3

12.9

1443

11930

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.3

12.9

113

489

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

6.1

12.8

A11CC03

ATC

alfacalcidol; systemic

2.1

12.8

141

676

M31.3

ICD-10 Finland

Wegener granulomatosis

5.2

12.8

I50

ICD-10 Finland

Heart failure

1.8

12.8

223

1269

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

12.8

474

3278

N06AX11

ATC

mirtazapine; oral

1.3

12.7

1538

12834

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

12.7

995

7844

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

12.7

555

3972

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.4

12.6

105

441

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

12.6

236

1371

I73.0

ICD-10 Finland

Raynaud syndrome

2.9

12.6

275

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

3.3

12.6

189

ZY010

NOMESCO Finland

Hospital outpatient

1.9

12.6

170

885

2770A

ICD-9 Finland

Other and unspecified disorders of metabolism, Cystic fibrosis

+∞

12.5

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

12.5

329

2103

291

Kela drug reimbursment

Tofacitinib

10.0

12.4

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

12.4

131

618

V03AE01

ATC

polystyrene sulfonate; oral

2.5

12.4

370

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

12.4

401

2695

Z94.0

ICD-10 Finland

Kidney transplant status

3.2

12.4

197

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

12.3

206

1156

D07XC01

ATC

betamethasone, combinations; topical

1.4

12.3

632

4656

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

12.3

521

3702

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

12.3

452

3122

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.9

12.3

172

909

C07AB02

ATC

metoprolol; systemic

1.3

12.2

1370

11315

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.7

12.2

300

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

9.0

12.2

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

37.6

12.2

WX402

NOMESCO Finland

General anaesthesia

1.4

12.2

710

5344

R04.0

ICD-10 Finland

Epistaxis

1.5

12.2

431

2955

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.2

12.2

122

563

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

12.2

1036

8261

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

12.2

269

1642

3AC01

NOMESCO Finland

3.0

12.1

222

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

12.1

231

1350

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

12.1

395

2658

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

12.1

585

4267

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.9

12.0

174

929

1CX08

NOMESCO Finland

4.3

12.0

100

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.5

12.0

421

2879

J01FA01

ATC

erythromycin; systemic

1.4

11.9

533

3829

TGD00

NOMESCO Finland

Needle biopsy of lung

4.1

11.9

110

RD210

NOMESCO Finland

2.6

11.9

324

B03XA02

ATC

darbepoetin alfa; parenteral

2.2

11.9

119

545

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

6.8

11.9

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.7

11.8

136

UGC02

NOMESCO Finland

Rigid bronchoscopy

6.6

11.7

L01CB

ATC

Podophyllotoxin derivatives

7.3

11.7

R53

ICD-10 Finland

Malaise and fatigue

1.3

11.7

1076

8669

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.6

11.6

320

2069

J86.9

ICD-10 Finland

Pyothorax without fistula

3.0

11.6

218

M79.6

ICD-10 Finland

Pain in limb

1.2

11.6

1737

14828

SPAT1325

SPAT

Vaccination

1.2

11.6

2008

17410

A01AB04

ATC

amphotericin B; local oral

1.6

11.6

275

1714

AA1AD

NOMESCO Finland

CT of head and brain

1.3

11.6

1384

11516

GDA97

NOMESCO Finland

Other thoracoscopic incision, excision of lesion or repair of lung

18.9

11.6

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

11.6

1613

13661

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

11.5

745

5697

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

11.5

305

J32.4

ICD-10 Finland

Chronic pansinusitis

2.7

11.5

272

M25.5

ICD-10 Finland

Pain in joint

1.3

11.4

1211

9925

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

5.6

11.4

304

Kela drug reimbursment

Dornase alfa

120.2

11.4

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

120.2

11.4

WX704

NOMESCO Finland

Intubation

1.6

11.4

333

2186

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

11.4

421

2911

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.8

11.4

208

1200

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

11.3

323

2106

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

11.3

1264

10425

M01CB03

ATC

auranofin; oral

3.3

11.3

172

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

11.3

338

2229

N19

ICD-10 Finland

Unspecified kidney failure

1.7

11.3

220

1295

GBB00

NOMESCO Finland

Tracheostomy

2.6

11.3

310

R24

ICPC

Haemoptysis

3.6

11.3

136

ZX197

NOMESCO Finland

15.0

11.3

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

2.1

11.3

130

638

E000002

ATC

1.4

11.3

473

3356

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

11.2

314

2037

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.0

11.2

107

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

8.9

11.2

E000003

ATC

1.8

11.2

205

1185

N06DA02

ATC

donepezil; oral

0.6

11.2

153

2582

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

7.2

11.2

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

11.2

133

659

N18.0

ICD-10 Finland

End-stage renal disease

2.5

11.2

356

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

11.2

333

2196

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.5

11.1

339

2249

R03DC01

ATC

zafirlukast; oral

2.3

11.1

414

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

11.1

1299

10776

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

3.0

11.0

198

132

Kela drug reimbursment

Sarcoidosis

3.4

11.0

150

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.5

10.9

329

WX740

NOMESCO Finland

Nitrogen oxide therapy

6.6

10.9

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.0

10.9

200

J98.9

ICD-10 Finland

Respiratory disorder, unspecified

7.8

10.8

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

6.9

10.8

C10AA01

ATC

simvastatin; oral

1.2

10.8

2811

25297

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.5

10.8

336

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

10.8

726

5591

R74

ICPC

Upper respiratory infection acute

1.3

10.7

946

7569

J05AB01

ATC

aciclovir; systemic

1.3

10.7

951

7617

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

10.6

1624

13873

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

10.6

845

6670

N07BA03

ATC

varenicline; oral

1.8

10.6

177

995

ZX114

NOMESCO Finland

Intramuscular

2.5

10.6

308

N06DA03

ATC

rivastigmine; oral, transdermal

0.5

10.6

1657

C01BD01

ATC

amiodarone; systemic

1.8

10.6

188

1078

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

10.0

10.5

C10AA05

ATC

atorvastatin; oral

1.2

10.5

2271

20077

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

4.9

10.5

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

10.4

107

500

R60.0

ICD-10 Finland

Localized oedema

1.4

10.4

606

4557

XX7LW

NOMESCO Finland

7.3

10.4

NDL52

NOMESCO Finland

Tenosynovectomy of hand

3.9

10.4

105

51701

ICD-8 Finland

Other chronic interstitial pneumonia, Fibrosis interstitialis diffusa pulmonum essentialis (Hamman-Rich)

+∞

10.4

R03BB07

ATC

umeclidinium bromide; inhalant

3.4

10.4

146

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.9

10.4

154

830

N06DX01

ATC

memantine; oral

0.6

10.3

199

3103

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.6

10.3

281

M54.5

ICD-10 Finland

Low back pain

1.2

10.3

1456

12322

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.9

10.3

158

863

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.1

10.3

174

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

10.3

152

821

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.2

10.3

106

497

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.2

10.3

169

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

10.3

2056

18029

L04AA29

ATC

tofacitinib; oral

8.8

10.2

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

9.5

10.2

R03AC19

ATC

olodaterol; inhalant

3.8

10.2

112

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

3.8

10.2

112

H03AA01

ATC

levothyroxine sodium; systemic

1.3

10.2

1065

8700

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.9

10.2

143

760

N06AA09

ATC

amitriptyline; systemic

1.4

10.2

484

3518

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

5.9

10.1

R2110

NOMESCO Finland

Giving the first information

1.6

10.1

286

1867

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

10.1

731

5687

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.5

10.1

337

2284

XA421

NOMESCO Finland

Nocturnal polygraphy

5.1

10.0

A01AB10

ATC

natamycin; local oral

1.9

10.0

143

765

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.0

9.9

130

670

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.3

9.9

398

N17.8

ICD-10 Finland

Other acute renal failure

2.5

9.9

285

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.4

9.9

329

L95

ICPC

Osteoporosis

1.8

9.9

156

863

R96

ICPC

Asthma

1.4

9.9

400

2819

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.6

9.8

121

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.6

9.8

255

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

9.8

146

790

S22.3

ICD-10 Finland

Fracture of rib

1.5

9.8

334

2273

NDG74

NOMESCO Finland

Fusion of first IP joint

6.3

9.8

FXE00

NOMESCO Finland

Use of ECLA

20.0

9.8

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

9.8

409

2902

NDG30

NOMESCO Finland

Fusion of wrist, total

3.9

9.8

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.5

9.8

122

51709

ICD-8 Finland

Other chronic interstitial pneumonia, Unspecified

9.5

9.7

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.0

9.7

124

635

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

1.6

9.7

272

1771

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.3

9.6

145

UJD02

NOMESCO Finland

Gastroscopy

1.6

9.6

265

1721

A06AD11

ATC

lactulose; oral

1.3

9.6

910

7347

A12BA01

ATC

potassium chloride; oral

1.5

9.6

316

2134

RK250

NOMESCO Finland

3.8

9.5

104

R01AD01

ATC

beclometasone; nasal

1.3

9.5

648

4992

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.7

9.5

196

1174

L04AC07

ATC

tocilizumab; parenteral

6.3

9.5

L04AA11

ATC

[U] etanercept; parenteral

5.0

9.5

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

10.0

9.5

A10AE04

ATC

insulin glargine; parenteral

1.4

9.5

496

3666

R13

ICD-10 Finland

Dysphagia

1.5

9.5

324

2205

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.5

9.5

120

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

3.8

9.5

100

Coronary artery bypass surgery

1.7

9.4

183

1080

4038

NOMESCO Finland

100.1

9.4

E84.1

ICD-10 Finland

Cystic fibrosis with intestinal manifestations

100.1

9.4

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.2

9.4

435

ED1AA

NOMESCO Finland

Mandipular X-ray examination

3.5

9.4

121

E84.8

ICD-10 Finland

Cystic fibrosis with other manifestations

+∞

9.4

NG1DA

NOMESCO Finland

X-ray of knees

2.2

9.4

436

R05CB01

ATC

acetylcysteine; inhalant, oral

2.0

9.3

108

532

Z31.5

ICD-10 Finland

Genetic counselling

1.8

9.3

147

811

R06AX27

ATC

desloratadine; oral

1.3

9.3

962

7845

J01DA08

ATC

[U] cefaclor; oral

1.5

9.3

359

2507

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

3.3

9.3

138

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

9.3

523

3915

3A064

NOMESCO Finland

3.9

9.3

WX204

NOMESCO Finland

Axillary plexus blockaced

1.8

9.2

141

772

A12AA04

ATC

calcium carbonate; oral

2.1

9.2

467

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

9.2

135

729

Z71.8

ICD-10 Finland

Other specified counselling

1.3

9.2

1008

8277

L04AB05

ATC

certolizumab pegol; parenteral

6.0

9.2

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

4.3

9.2

D02AE01

ATC

carbamide; topical

1.5

9.2

301

2034

D07AA02

ATC

hydrocortisone; topical

1.3

9.1

575

4380

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

9.1

426

3089

A07EC02

ATC

mesalazine; oral, rectal

1.6

9.1

225

1423

R95

ICPC

Chron obstructive pulmonary disease

1.8

9.1

160

917

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

1.7

9.0

176

1041

207

Kela drug reimbursment

Chronic arrhythmias

1.3

9.0

948

7746

J99.1*M34.8

ICD-10 Finland

Respiratory disorders in systemic: sclerosis

36.7

9.0

B59

ICD-10 Finland

Pneumocystosis

9.0

ZX100

NOMESCO Finland

Oral

2.2

9.0

390

C08CA01

ATC

amlodipine; oral

1.2

9.0

2137

18981

J01DA06

ATC

[U] cefuroxime; systemic

1.3

9.0

671

5243

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

2.6

9.0

246

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

3.1

9.0

153

AN2

Balloon angioplasty, including several vessels

1.7

8.9

177

1053

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

8.9

318

2187

D11

ICPC

Diarrhoea

1.4

8.9

387

2767

TK810

NOMESCO Finland

Hemofiltration

3.2

8.9

143

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

5.4

8.9

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

8.8

537

4066

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.8

8.8

204

ZX121

NOMESCO Finland

Central venous catheter

4.2

8.8

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.0

8.8

113

580

XX4AW

NOMESCO Finland

9.5

8.8

J98.2

ICD-10 Finland

Interstitial emphysema

9.5

8.8

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

5.1

8.7

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.2

8.7

134

N06AX16

ATC

venlafaxine; oral

1.4

8.7

468

3474

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

3.8

8.7

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

14.0

8.7

137

Kela drug reimbursment

Uraemia requiring dialysis

2.8

8.7

185

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

50.0

8.7

K77

ICPC

Heart failure

1.9

8.7

130

706

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.0

8.7

488

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

8.6

442

3254

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

1.9

8.6

114

594

A07AA09

ATC

vancomycin; oral

2.3

8.6

327

B01AB04

ATC

dalteparin; parenteral

1.5

8.6

267

1781

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

8.6

141

793

R06AE09

ATC

levocetirizine; oral

1.3

8.5

514

3886

A05AA02

ATC

ursodeoxycholic acid; oral

2.6

8.5

235

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.4

8.5

412

3005

K51.5

ICD-10 Finland

Left sided colitis

2.0

8.5

485

EB1WA

NOMESCO Finland

3.3

8.5

126

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

8.5

206

1296

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.5

8.5

272

1830

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

8.5

582

4492

J01XB01

ATC

colistin; inhalant, parenteral

20.0

8.5

J67.8

ICD-10 Finland

Hypersensitivity pneumonitis due to other organic dusts

20.0

8.5

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

8.4

177

1068

Z94.1

ICD-10 Finland

Heart transplant status

5.1

8.4

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

4.1

8.4

XF622

NOMESCO Finland

Measurement of minute volume of heart

4.1

8.4

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.2

8.4

364

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.1

8.4

138

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

8.4

1998

17727

R04

ICPC

Breathing problem other

1.8

8.4

147

845

UDM02

NOMESCO Finland

Sinoscopy

2.0

8.4

482

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

7.8

8.3

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

7.8

8.3

M06

ICD-10 Finland

Other rheumatoid arthritis

3.2

8.3

128

5168X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Other specified alveolar and parietoalveolar pneumopathies

+∞

8.3

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

8.3

785

6327

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

8.3

371

2670

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.7

8.3

196

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.1

8.2

443

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.3

8.2

302

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.9

8.2

106

548

C02KX01

ATC

bosentan; oral

14.5

8.2

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.6

8.2

214

1374

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.2

8.2

388

WVA20

NOMESCO Finland

Medicine administration

1.9

8.2

108

563

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

6.5

8.2

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

8.1

229

1495

3006

Kela drug reimbursment

Baricitinib

7.5

8.1

293

Kela drug reimbursment

Baricitinib

7.5

8.1

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.0

8.1

487

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

8.1

1246

10609

R4130

NOMESCO Finland

Speech therapy

1.9

8.1

106

552

DHA10

NOMESCO Finland

Biopsy of cavity of nose

3.0

8.1

142

J98.1

ICD-10 Finland

Pulmonary collapse

3.0

8.1

148

L28

ICPC

Limited function/disability (L)

1.3

8.1

890

7310

I47.2

ICD-10 Finland

Ventricular tachycardia

1.8

8.1

127

703

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

8.1

2227

19991

F2682

NOMESCO Finland

6.8

8.0

XX1VW

NOMESCO Finland

Written report from radiologist

3.0

8.0

143

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.8

8.0

1243

FHL

Bronchoscopy and other therapeutic procedure

6.3

8.0

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

1.7

8.0

145

842

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.3

8.0

111

B07.9

ICD-10 Finland

Verruca simplex

1.8

7.9

126

700

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

1.6

7.9

184

1146

RS224

NOMESCO Finland

4.0

7.9

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

7.9

110

584

R01AD05

ATC

budesonide; nasal

1.4

7.9

320

2261

196

Kela drug reimbursment

Paricalcitol and cinacalcet

3.6

7.9

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

7.9

1621

14180

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.9

3364

31217

GD1LA

NOMESCO Finland

2.1

7.9

417

M01AH02

ATC

rofecoxib; oral

1.3

7.8

689

5503

M10

ICD-10 Finland

Gout

1.5

7.8

239

1590

AN4

Balloon angioplasty and drug eluding stent

1.6

7.8

207

1334

K76.9

ICD-10 Finland

Liver disease, unspecified

2.4

7.8

270

ZX140

NOMESCO Finland

Intra articular

2.9

7.8

155

J01XX08

ATC

linezolid; systemic

3.3

7.8

113

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.7

7.8

254

3575

UJF92

NOMESCO Finland

Capsular endoscopy

2.1

7.8

425

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

7.8

250

1684

6BA02

NOMESCO Finland

4.8

7.7

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.3

7.7

114

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.7

7.7

141

822

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

3.6

7.7

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

7.7

762

6179

L04AA37

ATC

baricitinib; oral

7.4

7.7

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

7.6

136

784

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

2.0

7.6

472

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.0

7.6

472

T90

ICPC

Diabetes non-insulin dependent

1.2

7.6

1263

10826

J17.3

ICD-10 Finland

Pneumonia in parasitic diseases

18.4

7.6

N05CD07

ATC

temazepam; oral

1.3

7.6

737

5963

N05BA04

ATC

oxazepam; oral

1.2

7.6

1180

10055

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

7.6

1217

10403

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

3.2

7.6

116

R03BB05

ATC

aclidinium bromide; inhalant

4.0

7.5

K29.7

ICD-10 Finland

Gastritis, unspecified

1.6

7.5

168

1035

SPAT1260

SPAT

Consultation of another employee

1.2

7.5

876

7237

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.6

7.5

1526

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

10.0

7.5

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

7.5

487

3726

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.0

7.5

494

B05DA

ATC

Isotonic solutions

3.1

7.5

128

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

2.7

7.5

168

SBA10

NOMESCO Finland

Measurement of excretion of saliva

2.6

7.4

186

R49.01

ICD-10 Finland

Functional dysphonia

1.8

7.4

122

689

D68.8

ICD-10 Finland

Other specified coagulation defects

2.7

7.4

169

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

7.4

175

1094

R07.3

ICD-10 Finland

Other chest pain

1.3

7.4

443

3351

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.2

7.4

307

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

2.1

7.4

361

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.4

7.4

317

2262

B37.03

ICD-10 Finland

Chronic atrophic candida infection in the mouth

5.0

7.4

7102A

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]

13.3

7.4

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

7.6

7.4

3005

Kela drug reimbursment

Tofacitinib

7.6

7.4

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.8

7.4

125

713

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

4.0

7.3

SBA00

NOMESCO Finland

Microbiological examinations

1.9

7.3

103

549

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

7.3

414

3101

J99.1*M33.9

ICD-10 Finland

Respiratory disorders in dermatopolymyositis

+∞

7.3

UGC08

NOMESCO Finland

Rigid bronchoscopy with biopsy of lung

+∞

7.3

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

10.8

7.3

NH1CM

NOMESCO Finland

Ankle and foot extensive MRI examination with 3 Tesla magnet

6.8

7.3

NHQ40

NOMESCO Finland

Amputation of toe

1.9

7.3

105

568

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

7.2

1984

17759

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.5

7.2

229

1539

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.4

7.2

667

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.9

7.2

503

A91

ICPC

Abnormal result investigation NOS

1.6

7.2

197

1282

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.5

7.2

230

1546

Z94.4

ICD-10 Finland

Liver transplant status

5.8

7.2

L04AB06

ATC

golimumab; parenteral

3.3

7.2

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.4

7.2

317

2278

A04

ICPC

Weakness/tiredness general

1.3

7.2

636

5085

SPAT1060

SPAT

Administration of oxygen

3.2

7.2

110

WNF00

NOMESCO Finland

Infection source and contact determination

3.1

7.1

116

R03AC18

ATC

indacaterol; inhalant

2.4

7.1

229

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1.8

7.1

111

614

S20

ICPC

Corn/callosity

1.9

7.1

102

552

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

7.9

7.1

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

1.8

7.1

115

649

C10AX09

ATC

ezetimibe; oral

1.3

7.1

540

4234

WX702

NOMESCO Finland

Supraglottic ventilation device

1.5

7.0

206

1362

S18

ICPC

Laceration/cut

1.2

7.0

2229

20168

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.3

7.0

254

R06AX22

ATC

ebastine; oral

1.3

7.0

627

5019

C08DB01

ATC

diltiazem; oral

1.4

7.0

354

2605

A02BA04

ATC

nizatidine; systemic

1.3

7.0

434

3303

PE1AT

NOMESCO Finland

Femoral artery PTA

2.1

7.0

364

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.5

6.9

218

1461

R03BB06

ATC

glycopyrronium bromide; inhalant

3.2

6.9

102

R5599

NOMESCO Finland

Other rehabilitation service

1.8

6.9

119

681

RK310

NOMESCO Finland

6.3

6.9

L03AA02

ATC

filgrastim; parenteral

1.7

6.9

126

733

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

5.1

6.9

I26

ICD-10 Finland

Pulmonary embolism

2.5

6.9

194

S92.3

ICD-10 Finland

Fracture of metatarsal bone

1.8

6.9

115

651

Z49.2

ICD-10 Finland

Other dialysis

2.9

6.9

140

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

4.2

6.9

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

1.8

6.9

115

653

5823

FHL

Lung avobiopsy and wedge resection

7.5

6.9

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.6

6.9

181

1168

D83.0

ICD-10 Finland

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

13.8

6.9

49300

ICD-8 Finland

Asthma, bronchiale

1.7

6.9

122

704

M48.0

ICD-10 Finland

Spinal stenosis

1.3

6.9

664

5367

C09CA01

ATC

losartan; oral

1.2

6.9

1279

11072

UDC00

NOMESCO Finland

Ear microscopy

1.4

6.8

342

2513

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.6

6.8

156

968

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

3.8

6.8

N06AB04

ATC

citalopram; systemic

1.2

6.8

973

8208

C02KX04

ATC

macitentan; oral

8.2

6.8

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.1

6.8

352

J70.3

ICD-10 Finland

Chronic drug-induced interstitial lung disorders

10.9

6.8

D07AD01

ATC

clobetasol; topical

1.3

6.8

678

5503

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.7

6.8

121

700

XQ860

NOMESCO Finland

Laser Doppler measurement/scan of capillary perfusion

40.1

6.8

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

4.5

6.7

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

1.8

6.7

117

671

A10AA01

ATC

1.9

6.7

531

L01BB01

ATC

4.7

6.7

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.0

6.7

370

8041/3-C34.3

ICD-O-3

Small cell carcinoma, NOS, of lower lobe, lung

7.2

6.7

RF220

NOMESCO Finland

2.0

6.7

397

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

3.5

6.7

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.7

6.7

160

E66.8

ICD-10 Finland

Other obesity

1.6

6.6

159

1001

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.0

6.6

426

RJ412

NOMESCO Finland

6.4

6.6

RS310

NOMESCO Finland

7.8

6.6

-44

ICPC

Preventive immunization/medic

1.3

6.6

431

3305

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.5

6.6

202

1351

XG430

NOMESCO Finland

Spiroegometry

12.2

6.6

R76.0

ICD-10 Finland

Raised antibody titre

4.6

6.6

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

2.4

6.6

206

B01AB10

ATC

tinzaparin; parenteral

1.4

6.5

319

2336

RJ420

NOMESCO Finland

3.6

6.5

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.2

6.5

882

7399

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.0

6.5

394

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.3

6.5

246

-1

NOMESCO Finland

1.2

6.5

1313

11443

M02AA07

ATC

piroxicam; topical

1.2

6.5

1924

17298

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

2.6

6.5

165

5CM18

NOMESCO Finland

3.2

6.5

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.6

6.5

159

1010

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

3.9

6.5

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

6.2

6.4

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

3.7

6.4

A03FA02

ATC

cisapride; oral, rectal

1.3

6.4

390

2958

J98.6

ICD-10 Finland

Disorders of diaphragm

3.3

6.4

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.5

6.4

176

1148

B01AF02

ATC

apixaban; oral

1.3

6.4

563

4493

T08

ICPC

Weight loss

2.1

6.4

327

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.6

6.4

157

997

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.4

6.4

210

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

2.9

6.4

129

TNG10

NOMESCO Finland

Puncture of knee

2.3

6.4

241

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

3.0

6.4

109

GDB01

NOMESCO Finland

Thoracoscopic resection of bullae of lung

14.3

6.4

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

14.3

6.4

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.1

6.4

295

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.3

6.4

242

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.0

6.4

365

B05DB

ATC

Hypertonic solutions

3.0

6.4

115

I95.9

ICD-10 Finland

Hypotension, unspecified

2.0

6.3

407

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

1.9

6.3

435

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

6.3

1276

11116

XQ848

NOMESCO Finland

Dermatological photography

1.7

6.3

124

739

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

6.3

401

3063

J92

ICD-10 Finland

Pleural plaque

6.5

6.3

B37.0

ICD-10 Finland

Candidal stomatitis

2.4

6.3

205

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.3

6.3

371

2801

WX213

NOMESCO Finland

Lower leg blockade

2.7

6.3

154

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.3

6.3

244

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.5

6.3

188

1247

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.6

6.3

168

1087

NXL00

NOMESCO Finland

Biopsy of muscle

4.2

6.3

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

6.3

292

2121

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.5

6.3

180

A11

ICPC

Chest pain NOS

1.4

6.3

352

2639

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.1

6.3

299

3028

Kela drug reimbursment

Mepolizumab

18.0

6.3

297

Kela drug reimbursment

18.0

6.3

N06AB03

ATC

fluoxetine; oral

1.3

6.3

487

3827

A10AE05

ATC

insulin detemir; parenteral

1.4

6.2

253

1793

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

3.7

6.2

M33

ICD-10 Finland

Dermatopolymyositis

+∞

6.2

6BB16

NOMESCO Finland

+∞

6.2

E000006

ATC

1.4

6.2

301

2201

AA1

Conventional CABG

1.6

6.2

135

827

B03AX

NOMESCO Finland

26.7

6.2

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

1.8

6.2

100

564

J43.1

ICD-10 Finland

Panlobular emphysema

7.0

6.2

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.2

6.2

280

QDB00

NOMESCO Finland

Suture of skin of lower limb

2.8

6.2

127

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.4

6.2

281

2030

C61

ICD-10 Finland

Malignant neoplasm of prostate

0.8

6.2

427

5392

JN4CD

NOMESCO Finland

Very extensive body CT

1.5

6.2

206

1401

P70

ICPC

Dementia

0.5

6.2

783

K07

ICPC

Swollen ankles/oedema

1.5

6.2

229

1594

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

5.0

6.2

M05BA01

ATC

etidronic acid; systemic

2.7

6.2

150

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.6

6.2

157

1005

XJC00

NOMESCO Finland

Oesophageal manometry

3.6

6.2

G30.8

ICD-10 Finland

Other Alzheimer disease

0.5

6.2

828

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

2.8

6.1

128

AN3

Balloon angioplasty and metallic stent

1.5

6.1

174

1142

212

Kela drug reimbursment

Gout

1.6

6.1

131

802

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.0

6.1

357

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

2.8

6.1

129

B34.9

ICD-10 Finland

Viral infection, unspecified

1.8

6.1

499

SPAT1059

SPAT

Spirometry at the office

1.4

6.1

248

1761

D01AC02

ATC

miconazole; topical

1.3

6.1

402

3088

J93.9

ICD-10 Finland

Pneumothorax, unspecified

2.9

6.1

122

V03AE03

ATC

lanthanum carbonate; oral

4.0

6.1

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.0

6.1

373

A10AA02

ATC

1.6

6.1

156

1002

L03

ICPC

Low back symptom/complaint

1.2

6.0

1028

8819

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

3.1

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3000492) Spirometry study

1338

4454

3.46

323.31

2.8

1.4

—

(4010399)

1251

4001

3.57

321.65

2.0

1.4

—

(3018010) Neutrophils/100 leukocytes in Blood

4675

26671

3.11

307.65

11.8

5.6

60.7

58.4

30.48

4556

24594

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

804

1378

6.44

307.65

1.9

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

911

979

10.50

307.65

2.0

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

791

353

25.02

307.65

2.2

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

639

995

6.94

307.65

12.2

4.7

iu/ml

1404.7

2014.6

0.13

148

141

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

768

801

10.60

307.65

2.0

1.3

—

(44790048)

499

591

8.99

307.65

2.6

1.3

—

(44790049)

499

591

8.99

307.65

2.6

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

1002

2670

4.19

307.65

1.6

1.2

u/ml

257.1

234.9

0.31

936

2424

(3027801) Oxygen [Partial pressure] in Arterial blood

1968

7742

3.12

307.65

9.9

6.7

kpa

10.2

12.0

67.00

1883

7320

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

688

888

8.45

307.65

1.8

1.3

—

(42870588) Differential panel, method unspecified - Blood

3992

19760

3.27

307.65

11.2

5.5

—

(3022096) Basophils/100 leukocytes in Blood

4668

25732

3.28

307.65

12.1

5.7

0.6

0.7

2.98

4560

23708

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2160

8108

3.37

307.65

1.4

1.3

iu/ml

58.6

36.3

4.55

750

2461

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

453

203

23.73

307.65

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

4991

28720

3.36

307.65

11.6

5.5

e9/l

1.9

0.38

4606

24762

(3015171) Extractable nuclear Ab [Units/volume] in Serum

932

1683

6.21

307.65

1.3

1.2

u/ml

1.8

1.0

0.85

159

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1971

7744

3.12

307.65

9.9

6.7

kpa

5.1

0.04

1884

7336

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1001

1384

8.23

307.65

2.3

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

661

803

8.96

307.65

2.3

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

713

946

8.25

307.65

1.2

u/ml

45.6

0.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1507

2369

7.76

307.65

1.6

1.5

u/ml

14.0

19.0

0.36

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

576

796

7.77

307.65

1.2

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1123

3054

4.17

307.65

2.1

1.8

g/l

1.1

1.4

4.11

1045

2718

(3019060) Gas panel - Arterial blood

1494

4522

3.90

307.65

5.8

4.6

—

(3013115) Eosinophils [#/volume] in Blood

5052

29110

3.42

307.65

12.2

5.6

e9/l

0.2

7.04

4675

25025

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

876

2164

4.47

307.65

1.8

u/l

38.2

38.5

0.12

792

1846

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

612

930

7.09

307.65

1.3

1.2

u/ml

18.7

2.2

1.85

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

595

658

9.76

307.65

2.5

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1440

3881

4.38

307.65

4.0

2.5

g/l

10.3

10.6

1.26

1373

3509

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

688

1100

6.80

307.65

1.4

1.2

titre

160.8

129.1

0.11

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1989

7613

3.22

307.65

1.3

1.2

u/ml

27.6

13.0

2.70

592

2767

(3019069) Monocytes/100 leukocytes in Blood

4719

26585

3.21

307.65

12.6

6.0

8.9

0.18

4608

24549

(44790047)

499

591

8.99

307.65

2.6

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

652

776

9.13

307.65

1.8

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1987

7492

3.27

307.65

2.6

1.8

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

657

1111

6.40

307.65

1.4

1.2

u/ml

7.6

2.9

0.83

111

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1126

1370

9.54

307.65

1.9

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1121

1847

6.99

307.65

1.8

1.5

titre

260.4

274.1

0.06

(3037522) Nuclear Ab [Titer] in Serum

2439

6280

5.34

307.65

1.5

1.3

titre

604.3

503.4

1.69

719

1317

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2510

10918

2.98

307.65

2.7

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1421

2234

7.66

307.65

3.1

2.7

—

(3001604) Monocytes [#/volume] in Blood

4967

28032

3.44

307.65

11.5

5.4

e9/l

0.7

0.6

26.46

4543

23753

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

631

844

8.09

307.65

1.5

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

889

1536

6.46

307.65

1.7

1.4

iu/ml

12.9

16.5

0.33

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

707

1438

5.34

307.65

1.8

1.5

g/l

1.2

0.73

681

1359

(3013650) Neutrophils [#/volume] in Blood by Automated count

5123

32750

2.92

307.65

15.3

8.5

e9/l

4.8

4.3

36.86

4746

28243

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

673

1207

6.04

307.65

1.4

1.2

u/ml

40.6

48.6

0.24

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

660

1127

6.34

307.65

1.4

1.2

u/ml

13.3

6.8

1.23

144

184

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

780

1018

8.46

307.65

2.3

1.6

—

(3042631) Mycobacterium sp identified in Specimen

634

900

7.62

307.65

3.0

2.6

—

(3003396) Base excess in Arterial blood by calculation

1952

7716

3.09

307.65

10.0

6.7

mmol/l

1.6

1.1

4.77

1602

5939

(3006184) Hemoglobin [Mass/volume] in Capillary blood

741

1485

5.44

307.65

2.4

2.2

g/l

126.5

127.6

0.32

315

1122

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

704

1388

5.51

307.65

1.8

1.5

g/l

0.2

2.18

675

1314

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

984

1328

8.41

307.65

2.3

1.5

—

(3006504) Eosinophils/100 leukocytes in Blood

4711

26442

3.22

307.65

12.2

5.7

2.8

2.9

1.05

4596

24336

(44806118)

499

591

8.99

307.65

2.6

1.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

4727

27112

3.13

307.65

12.4

5.9

24.2

26.3

32.54

4610

24866

(3006315) Basophils [#/volume] in Blood

4977

28207

3.43

307.65

11.4

5.4

e9/l

0.0

8.29

4560

23940

(3037692) Legionella sp identified in Specimen by Organism specific culture

358

165

22.77

307.65

1.9

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1983

7532

3.25

307.65

2.5

1.7

—

(3023419) Bacteria identified in Sputum by Culture

700

724

10.59

307.65

2.7

2.4

—

(3023368) Bacteria identified in Blood by Culture

3354

18625

2.49

304.60

6.3

4.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

448

638

7.42

300.01

3.5

3.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

220

133

17.03

264.21

1.3

1.2

—

(3000494) Fungus identified in Specimen by Culture

1577

6444

2.85

263.04

2.3

1.4

—

(3016502) Oxygen saturation in Arterial blood

1655

6980

2.78

259.53

10.9

7.0

93.8

95.4

17.42

1597

6692

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

457

780

6.18

256.99

5.2

2.4

u/ml

609.6

2532.2

1.17

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

334

408

8.53

254.60

2.0

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

1317

4996

3.00

250.80

5.7

3.9

0.8

1.0

0.88

484

1504

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

310

352

9.15

250.38

2.1

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

309

350

9.18

250.05

2.1

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

158

34.34

249.40

3.0

1.9

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1219

4505

3.05

242.59

5.5

3.8

0.6

0.7

0.63

379

1048

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

591

1341

4.71

241.47

1.8

1.9

mg/l

11.0

12.2

1.55

553

1225

(3013637) Mi-2 Ab [Presence] in Serum

193

109

18.16

239.50

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

193

109

18.16

239.50

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

193

109

18.16

239.50

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

193

109

18.16

239.50

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1446

5924

2.80

237.78

1.7

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

355

506

7.32

236.98

2.0

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1018

3473

3.25

231.67

11.1

8.7

mmol/l

24.7

24.3

3.03

934

3195

(3027135) IgG subclass 1 [Mass/volume] in Serum

333

453

7.66

231.66

1.4

1.3

g/l

7.5

6.7

1.61

230

311

(3028192) IgG subclass 2 [Mass/volume] in Serum

332

453

7.63

230.34

1.4

1.3

g/l

3.0

2.9

0.61

232

315

(3024139) IgG subclass 3 [Mass/volume] in Serum

332

453

7.63

230.34

1.4

1.3

g/l

0.5

0.4

1.36

231

315

(4062490)

331

455

7.57

228.14

1.4

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

359

542

6.92

227.23

2.0

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

419

746

5.90

225.23

1.7

1.5

g/l

1.0

0.9

0.57

304

565

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4556

31364

2.21

222.75

9.8

6.1

umol/l

11.4

12.3

5.07

4419

29654

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

366

577

6.63

222.28

2.0

1.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

348

524

6.92

220.76

1.3

1.2

u/ml

55.7

47.9

0.18

(3025159) Blasts/100 leukocytes in Blood

1164

4408

2.95

220.35

5.8

4.0

0.2

0.4

0.37

402

1149

(3042936) Bacteria identified in Isolate by Culture

1832

8735

2.47

218.89

2.7

2.0

—

(3018418) pH of Serum or Plasma

3091

18467

2.17

214.96

6.1

4.1

7.4

0.62

711

3493

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4219

28443

2.15

213.92

10.7

6.1

mmol/l

1.2

9.04

3966

25521

(3021440) Promyelocytes/100 leukocytes in Blood

1208

4749

2.85

212.94

5.8

3.9

0.1

2.34

447

1394

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

424

840

5.30

202.70

1.4

1.2

u/ml

60.3

44.6

0.96

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

858

2872

3.25

200.14

2.6

1.9

ug/l

2.3

2.5

0.14

786

2484

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3312

20719

2.10

200.11

4.3

3.2

ng/l

2144.4

1814.5

2.46

2994

17955

(40760892) CBC W Ordered Manual Differential panel - Blood

2129

11381

2.23

191.27

8.7

4.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

473

1079

4.62

191.18

4.6

3.6

59.7

58.6

0.78

473

1079

(3004616) Nuclear Ab [Presence] in Serum

338

589

5.97

185.43

1.3

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4424

31464

2.04

180.68

11.8

6.8

mmol/l

1.2

4.23

3731

26370

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

250

327

7.88

179.64

4.0

3.5

—

(3021589) Normoblasts [#/volume] in Blood

3680

24621

2.00

177.60

19.1

10.1

e9/l

0.0

0.42

3149

19978

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

190

176

11.06

177.56

2.0

1.8

u/ml

59095.3

20327.3

0.28

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

257

364

7.28

172.18

1.2

1.1

u/ml

29.1

2.9

1.38

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1911

10209

2.18

168.64

6.5

3.1

mmol/l

0.8

0.27

1794

9443

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1364

6342

2.42

167.37

12.5

7.4

g/l

122.4

120.1

3.46

1318

6108

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

261

388

6.94

167.25

1.3

1.1

u/ml

66.2

34.9

1.02

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

259

386

6.92

165.57

1.3

1.1

u/ml

65.8

78.4

—

(3038026) Centromere Ab [Units/volume] in Serum

262

397

6.81

164.90

1.3

1.2

u/ml

42.3

65.6

0.43

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1013

4128

2.69

163.84

5.9

3.7

mmol/l

2.2

1.8

3.10

810

3009

(3020779) Urea [Moles/volume] in Serum or Plasma

1324

6148

2.41

162.51

12.8

6.6

mmol/l

11.4

11.1

0.73

1269

5800

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

398

908

4.58

160.47

1.5

1.4

—

(3009343) pH of Capillary blood

1029

4287

2.63

158.91

6.1

3.7

7.4

1.62

183

519

(3042733) HLA Ab [Presence] in Serum

152

118

13.13

158.90

4.3

4.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1038

4347

2.62

158.60

6.2

3.7

kpa

5.2

5.1

0.20

990

3961

(3013707) Erythrocyte sedimentation rate by Westergren method

5370

41885

2.08

158.38

9.2

4.1

mm/h

18.5

13.9

66.13

5210

38165

(1616796) Gas panel - Central venous blood

525

1495

3.71

156.56

5.7

3.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

392

903

4.53

156.09

1.4

u/ml

29.8

14.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

362

785

4.80

155.29

1.5

1.4

u/ml

129.8

123.3

0.14

172

(3007164) IgA [Mass/volume] in Serum or Plasma

1723

9098

2.17

154.79

1.9

1.5

g/l

2.8

2.6

2.64

1245

5221

(3011412) CD3 cells [#/volume] in Blood

278

479

5.99

154.11

2.3

2.1

e9/l

1.0

1.1

1.24

194

287

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2114

12104

2.05

153.01

2.5

1.7

mg/l

1.6

1.4

1.13

1739

9379

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1095

4810

2.50

150.93

2.1

2.2

nmol/l

339.0

377.7

6.17

1032

4368

(3017143) Hepatitis C virus Ab [Presence] in Serum

1072

4673

2.52

150.15

1.7

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2764

17479

1.94

149.67

5.2

3.1

u/l

34.7

36.2

0.39

2644

16420

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

249

404

6.35

146.62

1.4

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

922

3792

2.64

145.43

12.1

6.8

mmol/l

25.1

24.8

1.24

911

3755

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

273

500

5.63

141.86

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

273

500

5.63

141.86

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

273

500

5.63

141.86

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

498

1464

3.58

141.32

1.6

iu/ml

53.2

4.9

0.92

117

340

(3001964) Herpes simplex virus Ag [Presence] in Specimen

152

142

10.91

141.14

2.8

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

775

2985

2.79

138.77

1.4

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

994

4343

2.49

137.79

10.3

6.7

mmol/l

25.2

24.5

5.18

947

4047

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1275

6224

2.27

137.35

4.3

3.0

ng/l

274.0

243.9

1.25

1192

5703

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

171

195

8.96

137.30

3.5

1.8

ug/l

45.3

60.0

1.47

171

186

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

509

1554

3.45

136.16

3.5

2.3

g/l

3.9

3.6

3.09

496

1471

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1112

5155

2.37

135.01

1.7

1.5

—

(40758558) Short blood count panel - Blood

2339

14416

1.92

133.37

11.0

6.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

228

373

6.28

133.11

2.1

1.9

71.6

70.7

0.29

219

349

(3024471) HLA-A [Type]

139

125

11.32

132.39

1.0

—

(3024932) HLA-DR beta [Type]

137

121

11.52

132.05

1.0

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

224

363

6.34

132.00

2.1

1.9

15.6

14.4

0.37

149

(3015235) Bicarbonate [Moles/volume] in Capillary blood

549

1801

3.22

130.65

5.0

3.0

mmol/l

25.1

24.9

0.67

507

1546

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

220

355

6.36

130.19

2.2

1.9

—

(3021901) Oxygen saturation in Capillary blood

450

1311

3.59

129.26

4.4

2.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1561

8475

2.07

127.24

9.5

5.6

mmol/l

1.1

1.0

4.10

1462

7787

(40767503) Oxygen content in Capillary blood by calculation

470

1441

3.42

124.69

3.5

2.5

15.5

16.0

1.31

263

760

(3028626) Oxygen [Partial pressure] in Capillary blood

502

1610

3.28

123.87

5.5

3.1

kpa

7.7

7.9

2.88

483

1474

(3032080) INR in Blood by Coagulation assay

3724

26944

1.78

123.14

13.4

11.0

inr

1.3

3.37

1207

7360

(3024561) Albumin [Mass/volume] in Serum or Plasma

3752

27213

1.78

122.96

7.1

4.8

g/l

33.1

34.7

49.67

3514

25054

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1620

9066

2.01

120.65

3.4

2.6

20.8

21.8

2.25

1362

7608

(3027315) Oxygen [Partial pressure] in Blood

477

1509

3.31

120.29

7.6

4.2

kpa

8.2

8.4

2.05

468

1471

(36304419) Bacteria [Presence] in Urine

2590

16931

1.82

119.71

4.7

3.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5514

45154

1.92

118.14

14.3

7.5

u/l

80.1

80.7

0.34

5379

42202

(3022948) Iron [Moles/volume] in Serum or Plasma

1781

10365

1.95

118.13

3.3

2.5

umol/l

11.4

12.3

4.92

1681

9499

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

193

302

6.54

117.66

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

193

302

6.54

117.66

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

193

303

6.52

117.28

1.2

1.1

—

(3012501) Base excess in Blood by calculation

471

1502

3.28

117.19

7.7

4.1

mmol/l

2.8

2.6

0.78

362

1015

(3013290) Carbon dioxide [Partial pressure] in Blood

471

1503

3.28

117.06

7.7

4.1

kpa

5.0

0.76

462

1466

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

193

305

6.47

116.53

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

193

305

6.47

116.53

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

193

305

6.47

116.53

1.2

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1680

9633

1.97

116.12

3.3

2.5

g/l

2.2

2.3

1.25

1565

8845

(3010375) cycloSPORINE [Mass/volume] in Blood

162

213

7.76

115.73

42.5

23.3

ug/l

150.7

106.7

7.76

132

174

(3002582) Erythrocytes [#/volume] in Urine

2855

19359

1.78

115.68

5.0

3.5

e6/l

93.0

114.3

0.20

2348

15158

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

997

4736

2.28

112.99

1.9

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

470

1530

3.22

112.96

3.5

2.2

89.2

88.4

0.34

453

1440

(3026250) Tacrolimus [Mass/volume] in Blood

145

172

8.58

112.81

40.5

33.0

ug/l

8.0

7.3

1.93

132

155

(3010421) pH of Blood

508

1737

3.07

112.30

7.5

4.0

7.4

0.37

462

1468

(3030467) Casts [#/volume] in Urine by Automated count

2648

17688

1.78

112.01

4.8

3.3

e6/l

0.4

0.5

0.40

2125

13589

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1427

7830

2.02

111.28

4.6

4.0

u/l

269.4

248.2

4.50

1353

7344

(40757373) Influenza virus identified in Isolate

124

122

10.32

111.03

2.7

1.4

—

(3000991) Gas panel - Venous blood

1101

5509

2.18

109.59

12.7

7.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

215

403

5.47

108.83

2.2

2.1

31.9

40.7

1.28

(3026782) Osmolality of Urine

2055

12845

1.84

107.63

4.0

2.9

mosm/kgh2o

530.1

555.0

7.07

1848

10901

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

184

304

6.18

106.31

1.6

1.3

u/ml

1.9

1.6

0.12

122

147

(3018095) Leukocytes [#/volume] in Urine

3097

21874

1.72

105.95

5.9

3.9

e6/l

102.3

113.2

0.22

2428

16125

(3000850) Epithelial cells [#/volume] in Urine

2158

13758

1.81

105.51

3.9

2.7

e6/l

4.6

0.03

1962

12029

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

807

3600

2.40

105.37

16.1

9.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

154

224

7.00

100.55

1.4

1.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

4554

36000

1.71

100.26

9.3

4.8

mmol/l

6.9

0.78

4379

33826

(3014111) Lactate [Moles/volume] in Serum or Plasma

1117

5803

2.09

100.17

11.2

6.5

mmol/l

1.4

0.74

1058

5556

(3014576) Chloride [Moles/volume] in Serum or Plasma

1458

8338

1.94

99.67

12.1

6.6

mmol/l

103.9

104.4

4.17

1414

8145

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

423

1395

3.16

99.27

3.7

2.4

212.7

203.6

1.13

402

1331

(3023420) DNA double strand Ab [Units/volume] in Serum

218

451

4.95

98.65

1.9

1.3

iu/ml

22.3

27.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

202

392

5.27

98.37

1.3

1.2

titre

105.0

123.8

0.23

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

202

392

5.27

98.37

1.3

1.2

titre

122.1

142.3

0.19

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

292

762

3.95

98.15

1.2

u/ml

332.8

284.3

1.14

195

458

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

509

1879

2.84

97.73

1.8

1.7

—

(3002032) Base excess in Venous blood by calculation

1186

6373

2.03

96.74

5.4

3.7

mmol/l

2.3

1.9

2.56

985

5124

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

202

398

5.19

96.70

2.2

2.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

197

385

5.23

95.18

1.1

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

179

322

5.67

94.70

2.1

e6/l

481.3

514.2

0.29

148

268

(3020630) Protein [Mass/volume] in Serum or Plasma

1100

5797

2.06

94.49

2.3

2.5

g/l

65.8

66.0

0.18

1020

5165

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

302

830

3.75

94.26

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1181

6405

2.01

93.61

5.4

3.7

kpa

5.9

5.8

1.75

1130

6201

(3012544) pH of Venous blood

1212

6639

1.99

93.36

5.5

3.7

7.4

0.04

(3028433) Virus identified in Specimen by Culture

133

179

7.55

93.09

1.2

—

(3022313) Gas panel - Capillary blood

698

3099

2.39

91.58

6.5

3.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1976

12706

1.76

91.41

5.5

4.1

ng/l

445.2

477.7

0.13

1745

10796

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3176

23218

1.65

90.91

2.9

2.2

nmol/l

77.8

78.8

1.19

2925

20301

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

260

664

4.02

90.00

1.3

1.2

u/ml

4.2

3.7

0.09

101

193

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

168

299

5.73

89.89

1.7

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

168

299

5.73

89.89

1.7

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

168

299

5.73

89.89

1.7

1.8

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

243

595

4.19

89.04

1.2

1.1

117.3

114.8

0.48

233

517

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

146

229

6.49

88.77

1.7

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

146

229

6.49

88.77

1.7

1.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

948

4837

2.10

88.42

2.2

2.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

146

230

6.46

88.40

1.7

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

166

299

5.66

87.70

1.7

1.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

415

1459

2.96

86.96

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

415

1459

2.96

86.96

1.5

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

593

2517

2.48

85.74

4.1

2.9

u/ml

0.3

1.45

370

1430

(4306422)

244

618

4.05

85.41

1.3

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

345

1102

3.24

85.25

1.3

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

126

177

7.23

84.91

2.2

1.9

—

(3009871) Measles virus Ab [Titer] in Serum

104

9.64

84.53

1.3

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

249

646

3.96

84.32

1.3

1.2

u/ml

3.3

4.6

0.99

144

271

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

165

307

5.48

84.17

2.2

2.1

e9/l

0.2

0.42

146

267

(3036489) Thrombin time

500

1974

2.65

84.02

3.3

1.9

22.0

21.8

0.17

460

1761

(3027945) Reticulocytes/100 erythrocytes in Blood

1381

8181

1.85

82.95

3.5

2.4

1.9

1.8

8.87

1226

7134

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

200

445

4.59

82.87

1.4

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

333

1060

3.24

82.73

2.5

1.9

mmol/l

1.7

0.28

326

1034

(3013293) Extractable nuclear Ab [Presence] in Serum

13.64

82.63

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

187

406

4.70

79.85

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

2195

15001

1.66

78.94

6.6

4.0

84.4

84.9

0.41

2151

14620

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1049

5777

1.95

78.44

2.3

2.1

g/l

0.2

1.54

980

5335

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

197

456

4.41

77.66

1.2

1.1

95.4

94.5

0.16

191

420

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

672

3144

2.25

77.54

5.5

3.9

mmol/l

24.4

24.1

1.61

604

2804

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

234

624

3.84

76.21

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

108

8.80

74.98

1.7

1.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1591

10130

1.73

73.74

3.0

2.0

30.2

0.20

1552

9809

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

194

463

4.28

73.51

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

125

203

6.25

73.46

2.1

2.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2661

19333

1.59

73.37

3.4

2.1

u/l

165.6

226.6

3.45

2515

18004

(3014007) Fractional oxyhemoglobin in Arterial blood

813

4190

2.06

73.03

14.5

8.5

92.3

93.9

11.15

807

4171

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

10.94

72.93

1.3

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2280

16021

1.62

71.95

4.8

2.8

umol/l

3310.9

5662.0

2.18

2014

13583

(3037467) Urinalysis macro (dipstick) panel - Urine

4798

40114

1.58

69.55

6.8

4.6

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

799

4189

2.02

68.22

14.7

8.4

0.6

0.7

0.72

788

4154

(4268621)

178

424

4.28

67.62

2.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

759

3928

2.04

67.13

1.7

1.5

—

(4015189)

110

172

6.48

67.10

2.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

797

4203

2.01

66.88

14.6

8.3

1.4

1.3

1.53

785

4172

(3017569) Oxygen content in Arterial blood

155

334

4.72

66.80

2.2

2.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

790

4163

2.01

66.41

2.0

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

136

264

5.23

66.21

1.1

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

1061

6186

1.84

65.66

3.4

2.5

e9/l

74.0

67.8

5.08

756

4744

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

140

281

5.06

65.62

2.5

2.6

40.2

36.5

0.95

103

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

113

7.78

62.79

1.1

—

(3047181) Lactate [Moles/volume] in Blood

471

2073

2.36

62.37

11.0

5.9

mmol/l

1.4

1.3

0.84

434

1833

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

120

7.50

62.20

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2775

20912

1.53

62.14

4.4

3.3

mmol/l

2.3

5.42

2495

17843

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

148

331

4.54

60.95

2.4

2.2

e6/l

641.6

590.0

0.33

142

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

194

531

3.73

60.85

1.1

iu/ml

1.8

2.8

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

102

165

6.26

60.20

2.1

1.9

31.0

29.8

0.27

151

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

586

2878

2.13

59.36

8.2

4.9

1.8

1.6

4.79

547

2698

(3006245) CD3-CD19+ cells/100 cells in Blood

101

165

6.19

59.03

2.1

1.9

9.7

12.3

0.88

147

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2290

16701

1.54

58.83

2.6

2.3

mg/l

3.2

3.1

2.43

2019

14079

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2996

23182

1.50

57.88

3.7

2.9

ug/l

204.5

154.4

9.27

2762

20984

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

914

5291

1.83

57.35

5.8

3.9

mmol/l

1.2

4.25

834

4598

(3024354) Oxygen [Partial pressure] in Venous blood

910

5267

1.83

57.11

4.1

3.1

kpa

4.7

4.5

1.50

864

5079

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1522

10156

1.63

57.02

4.3

3.2

e6/l

1.7

2.0

1.23

872

5779

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

653

3391

2.02

56.83

1.9

1.6

g/l

1.6

1.04

552

2877

(3031040) Bacteria [#/volume] in Urine by Automated count

4629

39286

1.49

55.05

6.4

4.9

e6/l

1515.8

1898.0

0.18

664

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1078

6630

1.73

54.84

3.3

2.7

umol/l

9.7

9.3

0.23

937

5760

(3039000) Anion gap in Blood

361

1497

2.49

54.43

11.6

6.7

mmol/l

11.6

11.2

1.23

331

1338

(3018572) Chloride [Moles/volume] in Blood

361

1497

2.49

54.43

11.6

6.7

mmol/l

103.9

105.0

3.40

331

1338

(3019977) pH of Arterial blood

154

388

4.03

54.31

3.0

2.3

7.4

0.39

125

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

135

309

4.43

54.02

2.1

1.5

u/l

6.0

6.7

0.51

118

258

(3035350) Ketones [Presence] in Urine by Test strip

3470

27921

1.46

53.55

5.0

3.9

estimate

0.0

0.50

923

5134

(3007853) Bacteria identified in Skin by Aerobe culture

1130

7094

1.70

53.21

2.3

1.8

—

(3020891) Body temperature

545

2712

2.09

53.18

6.4

4.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

488

2330

2.17

53.00

3.6

2.2

ug/l

392.2

697.4

1.66

466

2207

(3034426) Prothrombin time (PT)

140

6.35

52.81

1.1

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

206

657

3.20

50.95

1.1

g/l

1.6

1.5

0.60

183

582

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

9.90

50.67

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

3449

27940

1.45

50.06

6.7

5.3

estimate

0.0

0.50

928

5178

(3009261) Glucose [Presence] in Urine by Test strip

3483

28305

1.44

49.47

5.0

4.0

estimate

0.0

1.60

898

5035

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1063

6686

1.69

49.40

5.0

3.7

—

(40761536) Microorganisms panel - Urine sediment

826

4855

1.79

48.82

5.3

4.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

551

2847

2.01

48.40

8.8

5.0

0.9

0.10

513

2671

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3103

24787

1.44

47.79

5.4

4.1

ng/l

101.7

77.2

0.17

2478

18856

(3034860) Kappa light chains.free [Mass/volume] in Serum

470

2316

2.10

46.94

2.7

3.1

mg/l

66.9

87.9

0.39

347

1898

(3024891) Influenza virus A+B Ag [Presence] in Specimen

316

1321

2.46

46.78

1.3

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

469

2314

2.10

46.68

2.7

3.2

mg/l

46.1

54.1

0.57

345

1897

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1554

10874

1.55

46.19

3.9

3.0

e6/l

1.0

1.1

0.82

907

6449

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

282

1129

2.56

45.76

1.4

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

457

2256

2.09

45.40

2.7

3.1

ratio

3.7

3.2

0.11

171

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

512

2655

2.00

44.43

7.4

4.1

mmol/l

25.0

24.7

1.64

488

2404

(3037756) Immunofixation for Serum or Plasma

343

1536

2.29

43.45

1.6

—

(3046861) Legionella sp Ag [Presence] in Urine

13.29

43.35

1.1

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

29.11

43.22

1.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

273

1110

2.52

42.88

4.0

3.6

1.5

0.06

238

822

(4035726)

855

5257

1.71

42.81

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

479

2465

2.01

42.43

5.1

3.9

mmol/l

1.4

0.23

470

2422

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

107

248

4.36

42.20

1.1

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

288

1213

2.43

41.93

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

410

2015

2.10

41.16

2.3

2.2

g/l

0.1

0.31

380

1817

(3023183) Ammonium ion [Moles/volume] in Plasma

301

1307

2.36

40.94

2.7

2.5

umol/l

32.8

34.4

0.47

271

1084

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

486

2548

1.97

40.80

2.4

2.3

g/l

3.3

3.1

5.38

389

1965

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

388

1875

2.13

40.71

2.4

2.2

g/l

0.0

1.04

358

1683

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

383

1842

2.14

40.68

2.4

2.2

g/l

0.0

0.00

358

1677

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

487

2564

1.96

40.38

2.4

2.2

g/l

10.6

10.2

0.91

410

2130

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

266

1102

2.47

40.15

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

512

2748

1.93

40.11

2.3

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

512

2750

1.93

40.02

2.3

2.2

g/l

7.9

7.4

4.93

394

1997

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

511

2744

1.93

39.97

2.3

2.2

g/l

3.9

3.8

0.54

384

1925

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2422

18948

1.42

39.68

3.2

2.6

u/l

61.1

59.1

0.34

2273

17406

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

287

1241

2.37

39.41

1.9

1.6

—

(3015736) pH of Urine

2740

21944

1.40

39.02

4.2

3.7

—

5.7

—

(3052851) Hemolysis interference index of Serum or Plasma

391

1933

2.08

38.62

4.6

3.5

—

(3002385) Erythrocyte distribution width [Ratio]

4986

44193

1.41

38.01

38.9

20.3

14.3

13.9

82.73

4932

43109

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

442

2313

1.97

37.26

2.3

g/l

0.7

1.1

1.36

392

1942

(3004119) Hemoglobin [Mass/volume] in Venous blood

694

4182

1.73

37.14

5.1

3.3

g/l

123.1

127.6

5.58

669

4077

(40760888) Immunoglobulin light chains.free panel - Serum

357

1736

2.11

36.82

2.7

3.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

185

4.64

36.30

1.1

u/ml

23.5

6.2

0.53

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

411

2121

1.99

36.04

2.3

2.1

g/l

35.8

37.3

5.02

371

1776

(3021788) Differential panel - Synovial fluid

253

1081

2.39

35.69

1.7

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

217

865

2.55

35.55

8.5

6.3

mg/l

12.2

12.1

0.03

202

790

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

320

1514

2.16

35.42

3.7

2.9

mg/l

1.9

1.7

2.92

294

1350

(3026008) Bacteria identified in Urine by Culture

2426

19272

1.39

35.29

3.8

3.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

395

2032

2.00

34.94

1.5

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

168

596

2.86

34.57

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3325

27923

1.35

33.49

3.0

2.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

238

3.99

33.04

1.2

ratio

1.1

0.25

(3034770) Mitochondria Ab [Titer] in Serum

287

1338

2.19

32.96

1.2

titre

1203.6

970.5

0.32

(3047007) Chlamydophila sp Ab [Presence] in Serum

162

581

2.83

32.69

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

116

5.47

32.62

1.1

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1880

14533

1.40

31.40

5.0

3.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

283

1338

2.16

31.38

1.2

titre

98.2

94.0

0.07

(3000060) B lymphocytes [#/volume] in Blood

104

5.61

30.90

2.2

1.8

e6/l

853.4

1400.9

0.20

(3024928) Oxygen saturation in Venous blood

283

1364

2.12

29.87

4.5

3.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

569

3445

1.71

29.72

5.1

3.4

mmol/l

25.6

25.1

1.97

538

3338

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

756

4933

1.59

29.39

5.1

3.8

ng/l

119.9

97.5

2.98

662

4152

(3043409) Potassium [Moles/volume] in Arterial blood

383

2086

1.88

28.58

5.9

4.1

mmol/l

4.0

3.9

2.89

348

1940

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

193

809

2.42

28.46

1.2

miu/ml

191.3

201.5

0.12

303

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

133

4.77

27.97

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

178

730

2.47

27.53

1.4

mmol/l

6.7

6.4

0.58

163

671

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

148

4.49

27.24

2.4

2.5

—

(40768446) Kidney Pathology biopsy report

187

4.04

26.98

1.6

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

802

5416

1.54

26.70

2.9

2.4

u/l

36.2

46.4

0.58

716

4602

(3003327) Ova and parasites identified in Stool by Light microscopy

289

1465

2.01

26.64

1.9

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

1942

15454

1.35

26.15

5.5

4.4

estimate

0.0

1.49

858

4905

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

186

799

2.36

25.99

1.2

—

(40768797) Stomach Pathology biopsy report

1101

7983

1.45

25.74

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

205

923

2.26

25.68

1.2

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

317

1696

1.91

24.98

1.5

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1550

11998

1.37

24.71

3.1

mmol/l

2.5

8.63

1370

10398

(3025941) Bacteria identified in Stool by Culture

475

2883

1.69

24.50

1.3

—

(3051651) Icteric interference index of Serum or Plasma

110

375

2.96

24.43

6.1

3.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

176

3.95

24.10

1.4

2.0

193.9

166.6

1.17

163

(3042111) Morphology [Interpretation] in Bone marrow Narrative

237

1163

2.07

23.90

1.8

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

168

718

2.37

23.78

4.7

4.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

216

1027

2.14

23.67

4.1

3.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

229

1114

2.09

23.64

1.5

g/l

31.6

31.3

0.15

199

990

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

307

1667

1.88

23.13

1.6

—

(3044889) 12 lead EKG panel

4490

40442

1.29

22.98

5.8

4.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

128

492

2.63

22.71

1.9

1.8

mg/l

4.9

4.6

0.20

118

469

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

175

3.85

22.66

1.0

1.1

98.6

91.9

1.32

125

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.39

22.55

1.3

1.4

—

(3012441) Differential panel - Pleural fluid

185

846

2.22

22.37

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1698

13515

1.33

22.19

4.3

3.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

166

730

2.30

22.04

1.1

—

(3004451) EKG impression Narrative

100

343

2.94

22.01

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

119

4.48

21.90

1.1

86.0

83.1

0.23

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

497

3148

1.62

21.68

4.1

2.7

0.7

0.81

486

3015

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

104

4.74

21.68

1.5

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

143

593

2.44

21.68

1.1

1.2

u/l

57.8

63.1

0.48

112

386

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

136

552

2.49

21.59

1.6

1.4

u/l

14.4

13.2

1.03

131

529

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1336

10316

1.36

21.22

1.3

1.2

u/ml

1.0

1.8

4.75

331

2586

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

141

587

2.43

21.20

1.3

u/l

14.2

13.3

0.16

122

535

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

457

2863

1.64

20.83

2.7

1.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1708

13729

1.32

20.59

1.9

1.8

nmol/l

1185.0

1157.3

0.54

1307

10207

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

167

759

2.23

20.53

1.4

1.3

u/l

429.4

370.9

0.36

156

717

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

163

738

2.24

20.23

1.7

1.5

58.9

61.8

0.40

100

485

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

123

4.25

20.13

1.1

1.3

86.1

82.3

0.25

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

7.97

20.00

1.1

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

7.59

19.93

1.2

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

7.59

19.93

1.2

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

6.48

19.16

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

150

3.82

19.13

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

103

4.49

19.10

1.7

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3785

33800

1.25

18.89

4.5

3.1

u/l

69.7

54.3

8.64

3520

30742

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

133

569

2.36

18.87

1.8

1.4

37.9

27.1

2.51

367

(3045142) Bone marrow Pathology biopsy report

157

721

2.20

18.85

1.5

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

369

2.71

18.74

1.7

1.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

268

1497

1.82

18.50

1.8

1.6

e6/l

13607.3

15663.7

0.26

204

1076

(3022493) Free Hemoglobin [Mass/volume] in Plasma

257

3.06

18.49

7.3

4.0

mg/l

63.6

67.1

0.18

176

(3045788) Cell count panel - Pleural fluid

160

751

2.16

18.20

1.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

239

3.12

18.15

7.8

6.6

mmol/l

25.3

24.7

0.39

217

(3045716) Anion gap in Serum or Plasma

314

2.82

18.10

2.9

2.1

mmol/l

8.4

9.4

1.69

249

(3044941) Cell count panel - Synovial fluid

189

948

2.02

18.04

1.7

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2505

21428

1.26

17.98

5.3

4.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

157

3.65

17.94

7.3

8.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5885

55536

1.31

17.76

35.3

16.7

mg/l

26.1

26.8

1.06

5507

45305

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

9.15

17.31

1.7

1.3

mg/l

1.2

2.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

322

2.75

17.29

3.7

3.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

129

3.90

17.28

1.6

1.5

ug/l

8.3

9.3

0.84

129

(3027456) Digoxin [Moles/volume] in Serum or Plasma

283

1640

1.75

17.27

3.2

3.1

nmol/l

0.9

0.8

0.41

225

1242

(3034891) Synovial lining cells/100 cells in Synovial fluid

274

2.90

17.14

1.7

1.4

4.1

3.6

0.14

(3019832) Treponema pallidum Ab [Presence] in Serum

338

2069

1.66

16.89

1.6

1.5

—

(40768806) Pleura Pathology biopsy report

172

855

2.04

16.86

1.5

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

697

5006

1.43

16.76

1.7

1.5

3.23

588

4225

(3021960) Folate [Moles/volume] in Serum or Plasma

1879

15647

1.27

16.65

1.8

1.6

nmol/l

18.8

20.1

3.16

1679

13256

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

9.11

16.42

1.6

1.3

mg/l

3.3

2.7

0.13

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

9.11

16.42

1.6

1.3

mg/l

2.2

0.9

0.35

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

9.11

16.42

1.6

1.3

mg/l

2.2

0.6

0.65

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

9.11

16.42

1.6

1.3

mg/l

1.3

3.1

0.62

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

9.11

16.42

1.6

1.3

mg/l

3.6

2.1

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

9.11

16.42

1.6

1.3

mg/l

3.5

1.1

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

9.11

16.42

1.6

1.3

mg/l

2.7

2.1

0.10

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

9.11

16.42

1.6

1.3

mg/l

1.5

1.3

0.10

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

9.11

16.42

1.6

1.3

mg/l

3.6

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

4.60

16.30

1.3

1.2

ng/l

117.3

1064.0

0.49

(3000570) Elastase.pancreatic [Mass/mass] in Stool

298

1782

1.70

16.27

1.4

ug/g

283.3

265.1

0.34

181

1089

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

100

4.22

16.18

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

339

2.62

15.68

1.1

1.2

u/l

105.1

95.1

0.38

286

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

328

2.64

15.63

1.1

1.2

u/l

41.4

26.1

1.16

271

(3038071) Oxygen [Partial pressure] in Mixed venous blood

135

3.65

15.46

7.2

8.3

—

(3019230) Fractional oxyhemoglobin in Venous blood

202

1096

1.87

15.36

4.7

2.6

65.9

63.4

0.91

202

1091

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

660

4790

1.42

14.93

3.9

2.7

ml/min/173m2

56.4

61.4

2.83

323

2021

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

470

3197

1.50

14.92

5.1

4.1

47.7

47.3

0.14

461

3154

(3051611) Lipemic interference index of Serum or Plasma

141

683

2.09

14.87

5.5

3.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

135

645

2.11

14.76

1.3

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

184

982

1.90

14.74

1.5

e6/l

3939.9

2146.7

0.42

128

724

(3013727) Leukocytes other/100 leukocytes in Blood

233

2.89

14.53

3.9

3.8

60.6

54.0

1.63

222

(3026389) Candida sp identified in Specimen by Organism specific culture

145

726

2.02

14.00

1.6

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

398

2650

1.53

13.98

2.4

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.55

13.81

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

832

6368

1.35

13.54

2.7

2.4

ug/l

10.0

7.0

3.36

729

5435

(3017732) Neutrophils [#/volume] in Blood

527

3739

1.44

13.50

3.4

3.2

e9/l

4.6

4.2

2.42

421

2687

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

330

2.50

13.42

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

330

2.50

13.42

1.5

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

151

780

1.96

13.37

1.1

1.0

—

(3017704) Immunofixation for Urine

392

2.36

13.30

1.6

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

742

5602

1.36

13.19

2.3

2.1

ug/g

187.9

157.3

1.21

611

4341

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

3.85

13.03

1.7

1.8

mg/l

6.3

9.6

2.76

(3028308) Erythrocytes [#/volume] in Pleural fluid

165

886

1.88

13.02

1.5

e6/l

107983.7

56491.1

0.84

539

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

418

2.29

12.78

1.4

1.2

—

(3035880) pH of Pleural fluid

100

451

2.23

12.69

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

153

809

1.91

12.67

13.3

16.3

mmol/l

7.5

7.4

0.10

135

661

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.49

12.57

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

2245

19548

1.21

12.45

3.7

3.2

mmol/l

7.0

7.4

3.59

1878

16082

(40768795) Lymph node Pathology biopsy report

116

561

2.08

12.36

1.3

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

104

3.67

12.17

1.3

1.2

titre

19.2

104.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.48

12.10

1.0

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.04

12.08

1.1

1.3

91.8

81.9

0.48

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.99

11.89

1.1

1.2

79.4

83.3

0.20

(40768804) Tissue Pathology biopsy report

2578

22842

1.20

11.72

2.4

2.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

184

2.89

11.61

1.9

2.1

u/l

66.0

41.7

0.36

170

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

366

2.31

11.60

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

141

748

1.90

11.60

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

354

2.33

11.57

1.5

1.6

u/l

10.4

6.0

1.33

159

(21491868) Cryoglobulin [Mass/volume] in Serum

190

2.86

11.54

1.3

1.2

g/l

0.3

0.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.35

11.48

1.3

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3039

27361

1.19

11.48

5.5

4.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

604

7959

0.74

11.35

10.6

8.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

320

2.39

11.35

1.0

1.1

u/ml

2.0

2.8

0.35

131

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.75

11.26

13.6

12.1

mmol/l

5.5

5.3

0.25

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

410

2.21

11.20

1.1

1.0

—

(3012516) Albumin [Mass/volume] in Urine

2183

19123

1.20

11.08

3.8

3.2

mg/l

716.8

335.5

2.45

1484

12318

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.37

10.95

1.7

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

346

2.30

10.81

1.0

1.1

u/ml

3.3

2.2

0.37

140

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

407

2.18

10.58

1.4

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

158

896

1.78

10.54

1.1

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

129

687

1.89

10.53

4.6

3.5

56.2

59.4

0.84

412

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

220

1384

1.61

9.99

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

417

2.12

9.97

1.1

u/ml

2.3

1.3

0.38

109

(3036048) Francisella tularensis Ab [Titer] in Serum

104

3.38

9.97

1.2

—

580.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

109

560

1.96

9.92

1.1

u/ml

1.4

2.2

0.43

236

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1620

13922

1.21

9.87

1.8

1.7

pmol/l

32956733.4

27487523.9

0.12

1326

11238

(3000012) Reticulocyte production index

400

2.14

9.81

1.9

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

2173

19210

1.19

9.67

3.5

2.6

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

158

925

1.72

9.48

1.5

1.8

ug/l

22.5

23.4

0.07

153

905

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

194

2.64

9.48

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

163

2.77

9.19

1.3

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

123

676

1.83

9.16

2.6

3.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

276

2.33

9.14

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

277

2.32

9.07

1.1

1.0

—

(44806071)

4.41

9.06

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

454

2.02

9.04

1.6

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

489

1.98

9.00

1.1

u/ml

3.5

3.7

0.06

239

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

462

2.00

8.97

1.6

1.4

—

(3011648) Oxygen content in Venous blood

470

1.99

8.92

5.0

2.2

10.6

10.9

0.36

470

(3006922) Hepatitis E virus Ab [Presence] in Serum

292

2.27

8.90

1.1

—

(40768443) Skin Pathology biopsy report

374

2693

1.41

8.88

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2267

20231

1.18

8.84

4.6

4.0

mg/mmol

16.4

9.8

4.55

1502

12893

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

597

7611

0.77

8.78

4.7

4.8

32.4

33.1

0.80

442

4957

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

106

564

1.89

8.75

1.2

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.24

8.64

1.5

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.24

8.64

1.5

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.24

8.64

1.5

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1167

9825

1.22

8.63

30.6

29.6

inr

1.5

0.11

125

1375

(3001893) Eosinophils/100 leukocytes in Pleural fluid

253

2.34

8.56

1.5

1.4

1.5

2.5

0.78

213

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

187

2.58

8.54

1.1

u/ml

14.3

2.0

1.11

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

8.47

8.46

1.4

1.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

7.51

8.41

1.1

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

106

3.12

8.35

7.5

7.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

232

2.38

8.29

2.8

2.5

—

(36660697) Celiac disease serology panel - Serum

489

3718

1.34

8.29

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

220

2.42

8.28

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

235

1576

1.51

8.12

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

234

1568

1.51

8.11

1.3

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

7.07

7.99

1.1

1.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

255

2.28

7.98

1.3

mmol/l

3.4

3.5

0.07

228

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.26

7.92

1.3

1.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

126

2.87

7.88

1.3

1.5

6.0

7.5

0.27

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

201

1313

1.55

7.85

1.6

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.58

7.83

2.3

1.5

umol/l

44.5

42.1

0.20

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.38

7.78

1.4

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

123

2.85

7.61

1.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

6.68

7.60

1.8

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2904

26631

1.15

7.59

2.2

2.1

pmol/l

91.7

93.2

0.97

1592

14015

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

229

1552

1.49

7.54

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

164

2542

0.64

7.53

1.3

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

282

2.17

7.46

1.0

u/ml

0.2

0.3

0.16

(3019768) Coxiella burnetii Ab [Presence] in Serum

5.18

7.44

1.8

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

309

2.11

7.42

1.4

63.7

68.4

0.43

253

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

194

2886

0.66

7.34

1.9

1.8

—

(3036603) Volume of Urine

392

1.97

7.31

1.4

1.7

1830.8

1782.8

0.10

103

(3037121) Protein [Mass/volume] in Urine

305

2202

1.40

7.19

3.1

3.0

g/l

0.5

0.3

2.33

156

930

(3041918) Cholesterol [Moles/volume] in Pleural fluid

150

2.61

7.18

1.2

mmol/l

2.3

1.5

1.11

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4344

41051

1.14

7.13

4.1

3.8

pmol/l

15.0

0.41

3938

36511

(3008401) Mugwort IgE Ab [Units/volume] in Serum

474

1.87

7.08

1.1

u/ml

0.5

1.2

1.28

211

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

163

2.52

7.06

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

380

2857

1.35

6.98

2.7

3.2

pmol/l

4.2

4.4

2.10

330

2486

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

358

1.99

6.95

2.5

1.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1875

20893

0.86

6.94

4.2

4.7

21.9

22.2

0.31

853

11056

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

298

2.09

6.90

1.5

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

136

2.66

6.87

1.7

1.6

ug/l

0.3

0.4

0.61

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

181

1192

1.53

6.87

1.1

u/ml

16.1

7.4

0.62

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

750

6169

1.24

6.87

1.4

1.3

—

(21494434) Karyotype in Bone marrow

102

583

1.76

6.78

1.3

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

169

1100

1.55

6.77

1.2

1.3

u/l

55.2

39.1

0.43

144

951

(3003181) Sodium [Moles/volume] in Urine

179

1180

1.53

6.77

1.5

1.3

mmol/l

65.0

62.7

0.32

164

943

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

841

7019

1.22

6.71

3.1

4.0

ug/l

21.4

26.2

0.19

699

5824

(3022145) Colonoscopy Study observation

770

6372

1.23

6.66

1.4

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

296

2.07

6.64

1.6

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

331

2.00

6.58

1.8

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

331

2.00

6.58

1.8

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

213

2.26

6.53

4.8

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

213

2.26

6.53

4.8

2.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

106

2.84

6.50

1.3

1.2

—

(3012565) Volume of 24 hour Urine

292

2.06

6.49

2.0

2.4

1748.2

1868.2

0.44

241

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1648

14644

1.16

6.42

3.3

2.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

3.21

6.41

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.29

6.40

4.3

4.6

—

(3007919) Fasciola sp Ab [Titer] in Serum

14.30

6.39

1.3

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

122

746

1.65

6.37

1.6

2.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

296

2.04

6.27

1.2

1.1

u/l

90.7

91.7

0.03

221

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

296

2.04

6.27

1.2

1.1

u/l

32.0

33.6

0.06

214

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.94

6.25

1.4

74.6

73.0

0.10

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

205

2.25

6.21

1.3

1.4

24.4

22.7

0.13

168

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

3.29

6.12

1.2

1.0

iu/ml

7.6

15.3

0.61

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.98

5.94

1.4

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

570

1.71

5.91

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

123

780

1.59

5.59

1.7

1.4

—

(44813793)

275

2.01

5.59

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

122

773

1.59

5.57

1.7

1.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.24

5.52

6.4

11.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

124

791

1.58

5.51

1.7

1.4

—

(3024263) Appearance of Synovial fluid

347

1.88

5.47

2.0

1.6

—

(44786800) Granulocytes/100 leukocytes in Body fluid

111

2.62

5.46

1.2

1.3

21.0

21.4

0.02

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

444

3534

1.27

5.44

2.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

121

770

1.58

5.43

1.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

121

771

1.58

5.41

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

121

774

1.57

5.32

1.7

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

359

1.85

5.26

1.0

mg/l

296.6

284.1

0.75

317

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.64

5.19

1.1

g/l

0.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.13

5.18

1.1

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

229

2.06

5.15

1.3

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.94

5.13

1.3

nmol/l

10.4

429039.8

0.72

(3042010) Triglyceride [Moles/volume] in Pleural fluid

115

2.53

5.11

1.2

mmol/l

0.4

1.7

1.27

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

158

2.28

5.10

6.3

2.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

3.89

4.98

3.3

3.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

253

1.98

4.96

1.1

iu/ml

7.1

12.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

124

1855

0.66

4.94

1.7

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

277

2099

1.33

4.93

1.4

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5342

55073

0.89

4.77

5.4

5.3

mmol/l

2.5

2.6

13.23

4806

49687

(3020393) Adenovirus Ag [Presence] in Stool

3.16

4.75

1.2

1.0

—

(3016750) Collection duration of Urine

382

1.76

4.63

2.2

2.0

min

473.7

493.6

0.69

269

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.40

4.56

2.5

5.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

262

1.91

4.52

1.4

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

306

1.84

4.46

1.5

1.3

nmol/l

1.3

1.2

0.58

228

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

3.10

4.35

3.2

2.5

mg/l

0.7

1.3

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

125

2.33

4.32

1.2

mg/l

195.7

38.2

0.36

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

543

1.61

4.32

2.1

2.0

u/l

5231.9

3025.5

0.30

218

(3020961) Endomysium IgA Ab [Titer] in Serum

265

2039

1.31

4.29

1.1

titre

451.0

208.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.27

4.18

1.3

—

(3016038) Potassium [Moles/volume] in Urine

433

1.67

4.15

1.3

1.1

mmol/l

32.6

34.6

0.38

359

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5154

53120

0.90

4.15

4.8

4.7

mmol/l

1.4

4.89

4609

47815

(3002523) Influenza virus A Ag [Presence] in Specimen

480

1.63

4.12

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

434

1.67

4.12

2.2

2.1

mmol/l

7.6

7.0

0.98

288

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5206

53618

0.90

4.11

4.9

4.7

mmol/l

4.4

4.5

8.06

4685

48624

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

201

2.00

4.10

5.1

1.7

umol/l

135.9

129.1

0.06

120

(3010144) Erythrocytes [#/volume] in Synovial fluid

606

1.56

4.09

1.7

1.3

e6/l

94429.5

134556.9

0.29

416

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1339

14791

0.88

4.00

2.9

3.2

ug/l

0.7

0.8

2.49

958

10542

(3025315) Body weight

3.13

3.92

5.9

5.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

481

1.61

3.85

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

249

1.85

3.82

1.2

1.3

ug/l

99.2

446.3

1.09

130

(3020876) Protein [Mass/time] in 24 hour Urine

593

1.54

3.81

1.9

g/24h

0.6

0.9

—

(3035320) C reactive protein [Mass/volume] in Body fluid

413

1.65

3.81

2.9

2.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

4982

48231

1.10

3.75

34.7

18.1

38.5

38.8

1.41

3149

30734

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

108

2.32

3.75

1.3

1.2

u/l

357.9

361.4

0.00

(1761868) Lipid panel - Serum or Plasma

1481

16193

0.89

3.69

3.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

6.67

3.67

3.4

4.8

—

(3028707) Methadone [Presence] in Urine by Screen method

312

1.74

3.64

2.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.61

3.63

1.5

1.2

ug/l

102.4

117.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

114

792

1.45

3.53

1.6

1.3

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.05

3.52

1.3

ml/s/173m2

0.8

1.0

—

(3001729) Color of Synovial fluid

2.70

3.48

2.4

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

101

1453

0.69

3.41

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

996

0.63

3.38

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

3.25

3.34

1.4

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

134

2.09

3.32

1.4

g/l

228.3

28.2

0.47

107

(3005011) Chlamydia sp Ab [Titer] in Serum

2.72

3.31

1.5

1.7

—

(3047189) Immunofixation for 24 hour Urine

353

1.65

3.27

1.7

1.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.16

3.21

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.58

3.20

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

363

1.63

3.20

2.0

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

164

1.96

3.18

1.1

miu/ml

1659.4

1593.8

0.10

164

(40768441) Liver Pathology biopsy report

380

1.61

3.15

1.5

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

515

1.52

3.14

1.3

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

678

1.45

3.14

1.5

—

(3008295) Osmolality of Serum or Plasma

636

1.45

2.98

1.3

mosm/kgh2o

271.6

278.6

2.08

473

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2471

26108

0.92

2.94

4.7

5.4

ug/l

3.4

3.9

0.36

2144

23135

(3045424) Erythrocytes [Presence] in Urine

134

993

1.36

2.92

1.8

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1581

14641

1.10

2.91

1.8

1.6

mmol/l

1.4

1.3

4.76

1314

12105

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.09

2.88

1.2

1.6

—

(3016135) IgD [Mass/volume] in Serum

6.67

2.86

1.3

1.2

mg/l

425.8

98.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.92

2.77

1.6

1.5

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

2.60

2.70

2.9

1.6

70.6

63.3

—

(3030313) Adrenal Ab [Titer] in Serum

4.21

2.67

1.4

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

528

1.46

2.64

2.1

1.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5018

51400

0.92

2.56

4.4

4.2

mmol/l

1.3

10.97

4460

45821

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.03

2.52

1.5

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

395

1.52

2.52

1.4

1.3

promille

1.1

1.2

0.19

305

(3013139) Helicobacter pylori Ag [Presence] in Stool

300

3569

0.83

2.48

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

225

1830

1.24

2.47

1.6

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.55

2.44

1.2

mmol/l

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

284

2370

1.21

2.43

2.9

3.3

u/ml

9554.1

1766.9

0.39

234

2025

(3004775) Volume in Urine collected for unspecified duration

555

1.43

2.42

2.4

2.2

571.9

646.7

1.01

346

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

145

1.87

2.41

1.3

g/l

0.4

0.3

1.58

116

(3000330) Specific gravity of Urine by Test strip

289

3437

0.83

2.39

4.8

3.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.75

2.37

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.22

2.30

1.6

1.4

—

(3014891) Appearance of Pleural fluid

112

1.97

2.29

1.9

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.38

2.29

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.62

2.27

1.3

1.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.56

2.26

2.3

1.5

5.2

14.8

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

455

1.45

2.25

1.2

1.3

titre

116.7

294.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

540

1.41

2.22

1.4

1.6

u/ml

15.0

26.4

2.50

124

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.56

2.21

1.2

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.05

2.21

1.3

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

157

1.79

2.20

1.1

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

165

1.76

2.18

2.3

1.8

—

(4027681)

226

1.64

2.17

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.02

2.15

1.1

u/ml

1.0

47.7

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.00

2.14

1.1

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

346

1.51

2.13

1.7

1.9

u/field

1.5

2.7

0.85

235

(3044290) Cell count panel - Cerebral spinal fluid

130

1011

1.29

2.12

1.2

1.3

—

(3044007) Cell count panel - Peritoneal fluid

167

1.74

2.10

2.3

2.0

—

(3052592) Norovirus Ag [Presence] in Stool

145

1.80

2.09

1.9

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

138

1.81

2.08

1.2

1.3

116.3

110.4

0.38

121

(40758292) HTLV I+II Ab panel - Serum

2.14

2.08

1.3

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.26

2.07

1.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

5.00

2.07

2.6

2.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.08

2.06

1.2

u/l

18.2

19.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

214

1.64

2.05

1.2

g/l

32.0

40.7

2.59

106

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

315

2699

1.17

2.05

1.2

iu/ml

111.8

135.2

0.57

949

(3035933) Granulocytes/100 leukocytes in Blood

110

1.91

2.05

2.2

1.7

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

4.00

2.04

1.0

—

(3048879) Bone marrow aspiration report

207

1.65

2.03

2.2

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

712

1.34

2.03

1.2

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

192

1.67

2.02

1.0

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

232

1.60

1.98

1.4

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

868

0.71

1.94

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

436

0.59

1.93

1.0

ng/l

300.5

323.8

0.16

288

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.45

1.92

1.0

1.1

—

(3019174) dRVVT (LA screen)

2.57

1.92

1.4

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

274

1.54

1.91

1.1

1.7

umol/l

5.7

10.4

1.29

190

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

135

1.78

1.90

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

122

957

1.28

1.90

1.4

u/l

11.0

10.3

0.19

100

768

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5302

53996

0.93

1.89

5.3

5.0

mmol/l

6.1

0.22

4770

48167

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

107

1.87

1.85

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

137

1705

0.80

1.85

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.53

1.83

8.5

5.7

umol/l

411.8

379.7

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

4.17

1.82

1.0

u/field

1.0

—

(3008898) HLA-B27 [Presence]

150

1214

1.24

1.81

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

160

1.69

1.81

1.4

1.6

g/l

14.5

14.6

0.01

127

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

348

3039

1.15

1.81

1.3

au/ml

41.4

58.3

0.57

125

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

254

1.54

1.80

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

191

1.63

1.80

2.1

1.8

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

439

0.61

1.79

1.0

ng/l

35.9

44.6

0.44

285

(3027008) Opiates [Presence] in Urine

693

1.32

1.79

2.0

1.9

—

(3016879) Cocaine [Presence] in Urine

642

1.33

1.77

2.0

1.9

—

(40765096) Chromosome analysis panel by Banding

200

1.60

1.76

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

437

0.62

1.76

1.0

ng/l

817.3

685.5

1.04

281

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

248

1.53

1.75

1.2

1.1

—

(3019150) Specific gravity of Urine by Refractometry

1342

12611

1.08

1.74

5.3

4.5

kg/l

1.0

0.05

241

1986

(3028300) Cannabinoids [Presence] in Urine

696

1.31

1.74

1.9

—

(3013512) EKG study

1957

18643

1.07

1.73

5.2

4.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.85

1.71

11.0

8.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

140

1.72

1.71

1.3

1.2

pmol/l

308.5

256.2

0.34

100

(3003694) ABO and Rh group [Type] in Blood

1498

14148

1.07

1.70

1.5

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

381

3365

1.14

1.70

2.3

2.4

au/ml

41.3

25.3

—

121

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

234

1.54

1.69

1.5

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

529

0.66

1.69

1.8

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

324

1.45

1.68

1.4

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

128

1028

1.25

1.68

1.5

1.4

iu/l

32.4

31.1

0.15

102

871

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

527

1.35

1.67

1.4

1.3

nmol/l

1.5

0.23

464

(3027944) Amphetamines [Presence] in Urine

684

1.30

1.66

1.9

1.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.80

1.65

4.9

10.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.80

1.65

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

161

1937

0.83

1.61

5.6

4.4

—

(3045462) Protein/Creatinine [Ratio] in Urine

2.50

1.59

3.1

4.4

g/mol

57.7

52.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.07

1.59

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

690

1.29

1.57

2.0

1.9

—

(3032773) Endomysium IgG Ab [Titer] in Serum

398

1.38

1.54

1.0

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

746

1.28

1.53

1.5

1.3

nmol/l

9.8

0.7

0.49

713

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5121

50330

1.06

1.47

5.1

4.7

mu/l

2.1

0.54

4682

45025

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

680

1.28

1.46

1.5

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

243

1.48

1.46

6.1

5.0

u/ml

43.0

56.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.37

1.45

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.73

1.43

1.3

1.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

245

1.47

1.41

1.1

1.2

60.7

64.1

—

(40761511) CBC panel - Blood by Automated count

5742

56650

1.06

1.40

28.3

16.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

149

1.61

1.40

1.9

2.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

134

1.64

1.38

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.94

1.38

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

1.34

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.87

1.34

1.6

1.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5896

58255

1.06

1.30

37.1

20.0

mmol/l

139.0

139.6

51.26

5817

56676

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

269

0.59

1.28

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

269

0.59

1.28

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

268

0.60

1.27

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

268

0.60

1.27

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

135

0.44

1.26

1.8

6.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

678

1.26

1.2

1.3

pmol/l

277.9

266.3

0.11

507

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

303

1.39

1.24

1.1

mg/l

259.4

293.8

0.75

260

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.22

1.24

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

511

1.29

1.24

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

753

1.24

1.22

1.5

1.3

nmol/l

0.1

0.3

1.81

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.16

1.21

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

246

1.42

1.20

3.3

2.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

357

1.35

1.19

2.2

2.1

ug/min

85.1

184.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

101

1.68

1.19

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

5976

60381

0.94

1.19

46.7

24.8

g/l

130.5

133.7

46.06

5915

59243

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

167

0.54

1.18

1.4

1.5

—

(3011288) Drugs identified in Urine by Screen method

454

1.30

1.17

6.9

2.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.70

1.17

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.93

1.16

1.2

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

357

0.67

1.15

1.8

1.7

—

(3026361) Erythrocytes [#/volume] in Blood

5976

60367

0.94

1.15

46.3

24.6

e12/l

4.3

4.4

28.19

5855

58281

(3024731) MCV [Entitic volume]

5976

60364

0.94

1.14

46.2

24.5

92.3

91.6

24.88

5915

59224

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

769

1.23

1.13

2.9

3.6

u/ml

25.2

34.3

0.90

743

(3035941) MCH [Entitic mass]

5976

60362

0.94

1.13

46.1

24.5

30.4

0.34

5916

59220

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

105

869

1.21

1.13

2.7

2.1

mg/l

23.0

25.4

0.20

207

(3007461) Platelets [#/volume] in Blood

5975

60351

0.94

1.13

46.4

24.6

e9/l

245.6

240.8

5.89

5873

58493

(3010813) Leukocytes [#/volume] in Blood

5978

60380

0.94

1.13

46.4

24.7

e9/l

7.8

6.9

71.83

5857

58291

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

318

1.35

1.12

1.2

1.1

mg/l

48.7

43.5

0.29

263

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

167

1.50

1.12

1.7

1.4

pmol/l

24.5

16.2

0.72

132

(3050129) First trimester maternal screen panel - Serum or Plasma

318

0.66

1.11

1.4

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

104

1.64

1.09

1.1

1.3

—

(4198724)

104

1.64

1.09

1.6

—

(4212803)

1.82

1.08

1.2

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

218

1.42

1.08

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

982

0.81

1.07

2.0

1.9

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5264

51938

1.05

1.07

7.1

6.5

mmol/mol

41.8

40.8

7.48

4869

47188

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

523

1.26

1.07

1.0

1.1

u/ml

14.9

2.7

0.83

182

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

758

1.22

1.06

1.1

iu/ml

65.2

273.1

0.48

154

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.12

1.05

1.0

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5898

58370

1.06

1.05

37.5

20.1

mmol/l

4.0

4.64

5814

56703

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

289

0.66

1.04

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.67

1.03

2.0

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

239

0.63

1.01

1.4

1.5

—

(3011985) Renin [Units/volume] in Plasma

726

1.21

1.01

1.2

1.4

mu/l

48.7

55.2

0.21

635

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.71

0.98

2.2

2.8

u/field

0.5

0.4

0.14

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

274

1.35

0.98

1.4

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

469

4341

1.09

0.97

2.6

2.1

nmol/l

12.3

12.1

0.24

404

3738

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

783

0.80

0.97

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

130

1116

1.17

0.97

1.2

mmol/l

3.8

3.9

0.22

120

1034

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

147

1275

1.16

0.96

1.3

mg/l

747.5

564.7

0.46

134

1197

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.96

0.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

558

5205

1.08

0.96

1.7

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

158

1379

1.15

0.95

3.0

3.2

u/ml

230.3

786.5

1.37

148

1258

(3032868) Hemoglobin electrophoresis panel in Blood

1.89

0.94

1.4

1.5

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.82

0.92

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

1.82

0.92

2.9

2.7

umol/l

434.2

573.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.82

0.92

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

366

1.29

0.90

2.3

2.6

umol/l

24.1

30.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

663

1.21

0.90

1.5

1.3

nmol/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

126

1087

1.16

0.90

3.4

1.6

nmol/l

1.1

0.8

4.01

103

898

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

151

1.46

0.90

1.0

1.2

22.7

28.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

160

1.44

0.88

1.0

1.1

u/ml

0.8

2.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

289

1.32

0.87

1.1

1.2

u/l

208.3

311.0

0.95

264

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

120

1.50

0.85

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.78

0.84

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

227

0.66

0.84

1.4

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

179

1.40

0.83

2.6

1.8

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

222

1.35

0.83

2.3

2.2

umol/l

57.2

56.7

0.02

178

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

275

1.31

0.81

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.61

0.81

2.2

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.61

0.81

2.2

2.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

215

1.35

0.80

2.3

e6/l

457.3

4242.8

0.57

157

(3008116) Ketones [Moles/volume] in Urine by Test strip

139

1.44

0.79

2.0

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.67

0.78

1.0

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

108

935

1.16

0.77

1.5

1.7

mu/l

331.1

297.4

0.51

860

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

191

1.36

0.76

26.1

17.6

nmol/l

1440.2

1432.7

0.02

186

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.77

0.76

5.2

3.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

288

1.29

0.75

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

124

1.45

0.75

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

192

1.36

0.74

2.0

e6/l

6959.1

17680.0

—

115

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.08

0.74

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.84

0.73

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

219

0.68

0.72

1.3

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.00

0.72

1.0

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.67

0.72

1.6

1.1

umol/24h

1.7

1.8

—

(3005033) Fetal Nuchal fold Thickness US

218

0.69

0.71

1.3

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

206

0.68

0.71

1.6

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

229

1.31

0.70

1.0

1.1

u/l

1.0

1.1

0.94

116

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

158

0.63

0.70

1.1

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.85

0.68

1.0

1.3

—

(4034850)

204

1858

1.10

0.67

13.4

11.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.79

0.66

5.8

9.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

124

1105

1.12

0.62

1.2

1.4

e6/l

487.5

971.1

0.52

905

(3033705) Calcium.ionized [Moles/volume] in Venous blood

110

976

1.13

0.60

3.7

2.4

—

(3003338) MCHC [Mass/volume]

4401

44510

0.97

0.60

41.8

22.0

g/l

329.1

331.8

66.26

4362

44045

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

473

1.19

0.58

1.1

—

25.9

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.56

0.58

1.5

1.3

—

609.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

184

1.31

0.57

19.3

12.2

nmol/l

885.1

832.8

0.21

174

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

123

1104

1.12

0.56

1.2

1.3

e6/l

84.9

22.9

0.54

859

(4094501)

135

1492

0.90

0.55

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

375

1.20

0.55

1.7

1.4

nmol/l

0.2

0.3

2.58

280

(3025130) Human papilloma virus identified in Specimen

376

1.20

0.54

1.8

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

241

2241

1.08

0.53

1.6

1.8

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.45

0.53

12.2

13.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

779

1.13

0.52

1.7

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

214

1.26

0.52

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

116

1045

1.11

0.51

1.4

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.50

0.51

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

443

1.18

0.51

1.7

2.0

ug/l

1.5

2.2

2.32

364

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.41

0.51

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

135

1.33

0.51

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

584

1.15

0.50

1.9

2.1

u/field

1.5

1.7

0.11

206

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

352

1.19

0.50

2.3

2.4

—

(3000034) Microalbumin [Mass/volume] in Urine

596

1.14

0.48

2.7

3.1

mg/l

90.9

48.9

0.49

450

(3033923) Metanephrine [Moles/time] in 24 hour Urine

119

1.35

0.48

1.3

1.1

umol/24h

0.7

—

(3014051) Protein [Presence] in Urine by Test strip

127

1393

0.91

0.47

2.9

2.3

—

(3026470) Cobalt [Mass/volume] in Blood

456

1.16

0.47

1.6

1.9

ug/l

3.0

3.6

0.46

392

(3023410) Appearance of Cerebral spinal fluid

468

1.15

0.45

1.3

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

656

1.13

0.45

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

220

0.77

0.44

1.1

ng/l

710.9

367.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

413

1.16

0.44

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.37

0.44

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

139

1.30

0.43

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

128

1394

0.92

0.43

6.5

3.8

mg/l

27.0

29.8

0.46

911

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

406

1.16

0.42

3.4

5.1

u/ml

85.5

53.1

0.27

118

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.47

0.40

2.4

2.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.43

0.39

1.0

1.1

—

(3002256) Pathology report gross observation

808

7847

1.03

0.38

1.4

—

(3006462) Nitrate [Presence] in Urine

298

1.18

0.38

5.5

3.8

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.35

0.37

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

152

1.25

0.36

1.0

1.1

u/ml

0.5

2.5

—

(40768793) Breast Pathology biopsy report

110

1012

1.09

0.36

1.4

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

375

0.85

0.36

1.3

1.4

u/l

34.1

29.9

0.28

307

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5874

58456

1.03

0.36

20.3

11.0

u/l

25.3

25.6

0.49

5779

55889

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

321

0.84

0.36

1.6

1.4

pmol/l

56.1

150.3

—

104

(4211845)

328

1.16

0.36

5.2

3.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

121

1121

1.08

0.35

1.7

iu/l

4.3

4.6

0.15

357

(3006442) Creatine [Moles/volume] in Serum or Plasma

386

1.14

0.34

2.2

1.7

umol/l

74.0

71.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

163

1.23

0.34

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

145

1.24

0.33

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

368

1.14

0.33

1.2

mmol/l

13.3

11.8

0.60

109

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

147

1.22

0.30

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

296

1.15

0.30

3.8

6.4

—

(3015183) Erythrocyte sedimentation rate

175

1.20

0.30

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

141

0.78

0.29

1.5

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

108

0.74

0.29

1.6

1.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

139

1.22

0.29

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

176

1670

1.06

0.28

4.6

3.3

mmol/l

1.6

1.7

0.14

170

1630

(44806420)

237

0.84

0.27

2.0

2.4

—

(3014271) Vancomycin [Susceptibility]

451

1.11

0.27

3.0

—

(1002224) Polysomnography panel

164

1555

1.06

0.27

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.19

0.26

1.1

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

263

1.14

0.25

1.0

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

166

1580

1.05

0.24

4.9

3.4

mmol/l

7.5

7.7

0.67

160

1544

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

397

1.11

0.24

2.5

3.5

nmol/l

78.6

174.4

3.56

392

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.17

0.24

2.2

2.6

pmol/l

31.0

75.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

294

1.12

0.23

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

263

0.87

0.22

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.19

0.21

1.2

2.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.19

0.21

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1316.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

1.6

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3045414) Leukocytes [Presence] in Urine

273

2641

1.03

0.21

2.3

2.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.21

0.0

6.3

—

42.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

210

2023

1.04

0.20

1.6

1.7

—

(3022621) pH of Urine by Test strip

419

4085

1.03

0.20

4.1

3.2

—

(3002619) Bacteria identified in Specimen by Culture

108

1.20

0.20

1.3

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.22

0.20

1.2

4.4

—

(40761535) Cells panel - Urine sediment

554

5423

1.02

0.20

4.7

3.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5207

51874

1.01

0.19

29.6

16.0

ml/min/173m2

72.9

74.3

4.58

4678

43037

(3025549) Creatine [Moles/time] in 24 hour Urine

1.15

0.19

1.7

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.15

0.19

1.0

—

(3049717) Cytology report of Urine Cyto stain

314

3055

1.03

0.18

2.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

142

0.84

0.17

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

563

1.07

0.16

1.2

mmol/l

7.2

7.7

0.79

400

(3036071) Salmonella sp Ab [Titer] in Serum

139

1.15

0.16

1.2

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

894

0.95

0.16

1.7

1.5

pmol/l

169.4

217.3

0.53

868

(4146454)

761

0.95

0.16

2.4

2.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

518

5272

0.98

0.15

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.13

0.15

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

208

1.11

0.14

2.1

2.8

umol/l

30.4

29.3

0.15

156

(3019225) pH of Specimen

667

6577

1.02

0.13

6.1

4.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

252

0.91

0.12

1.4

1.3

mmol/l

6.0

6.1

0.28

237

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

266

2605

1.02

0.12

1.4

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

269

1.08

0.11

1.3

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

139

1354

1.03

0.10

2.0

1.7

mg/l

24.0

3.5

6.50

122

971

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

116

1.12

0.09

2.1

3.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

951

1.03

0.09

1.9

pmol/l

201.0

198.9

0.07

884

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.09

0.08

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

204

1.08

0.08

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.05

0.08

1.0

1.2

u/l

7.8

11.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.83

0.08

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.83

0.08

1.0

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.04

0.08

2.3

1.9

—

(3037556) Urate [Mass/volume] in Serum or Plasma

205

1.07

0.07

1.4

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

186

1.08

0.07

1.1

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.86

0.07

1.1

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

153

0.91

0.07

2.0

2.2

mmol/l

7.6

8.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.07

0.07

3.2

2.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

345

0.96

0.06

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

129

1.09

0.05

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

395

0.96

0.05

11.0

12.3

—

(3024869) Neuronal Ab [Presence] in Serum

120

1.08

0.04

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

170

1679

1.01

0.04

2.6

2.3

ug/min

156.1

104.6

0.62

103

977

(3006270) Folate [Moles/volume] in Blood

576

1.02

0.04

1.2

nmol/l

315.2

334.4

0.28

457

(4024509)

636

1.02

0.04

1.6

—

(4133840)

129

0.93

0.03

1.0

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

226

2241

1.01

0.03

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

159

0.94

0.03

2.0

2.4

ug/l

1.8

1.3

0.34

149

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

112

1.07

0.03

2.4

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

112

1.07

0.03

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

771

0.99

0.02

5.3

4.3

umol/l

349.3

347.0

0.04

656

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

158

0.95

0.02

1.0

1.3

nmol/l

90.9

137.9

—

118

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

134

1351

0.99

0.02

1.6

1.7

—

(3022689) Creatine [Moles/volume] in Urine

163

1.04

0.01

1.5

—

(3000285) Sodium [Moles/volume] in Blood

104

1.06

0.01

1.2

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

215

2143

1.00

0.00

3.2

3.8

u/ml

57.4

71.4

0.42

207

2050

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

101

0.99

0.00

1.3

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

119

1.01

0.00

2.0

1.5

ng/l

162.3

142.8

0.21

119

(4281824)

537

1.01

0.00

1.1

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

40.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.8

—

14.0

—

(3049233) Organic acids panel - Urine

0.00

0.0

1.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.94

0.00

1.2

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.02

0.00

1.0

—

(4038314)

0.00

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.8

—

0.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.99

0.00

1.0

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.90

0.00

1.1

1.2

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.8

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: J10_INTERSTITIUM – Other respiratory diseases principally affecting the interstitium

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other respiratory diseases principally affecting the interstitium

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other respiratory diseases principally affecting the interstitium (J10_INTERSTITIUM)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints